{
  "entity_atoms": [
    {
      "instance_id": "inst_0",
      "canonical_id": "ent_1",
      "text": "Mechanical biliary obstruction",
      "label": "ENTITY",
      "start_char": 1,
      "end_char": 31,
      "sentence_text": "Mechanical biliary obstruction results in raised levels of ALP, GGT and often bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0400979",
          "score": 0.784,
          "definition": "Blockage in the biliary tract that carries bile from the liver to the gallbladder and small intestine. Causes include gallstones, biliary tract strictures and inflammation, pancreatitis, cirrhosis, lymph node enlargement, and bile duct and pancreas neoplasms.",
          "aliases": [
            "Biliary Obstruction",
            "biliary tract obstruction",
            "Obstruction of biliary tree (disorder)",
            "biliary obstruction",
            "biliary obstructions"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_1",
      "canonical_id": "ent_2",
      "text": "results",
      "label": "ENTITY",
      "start_char": 32,
      "end_char": 39,
      "sentence_text": "Mechanical biliary obstruction results in raised levels of ALP, GGT and often bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0456984",
          "score": 0.822,
          "definition": "The result of a laboratory, radiologic, or other clinical test performed to determine the presence, absence, or degree of a condition.",
          "aliases": [
            "test finding",
            "Clinical Test Result",
            "Diagnostic Test Result",
            "Test finding",
            "test result"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3244125",
          "score": 0.809,
          "definition": "<b>Description:</b>Lab Results Attachment",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C4684761",
          "score": 0.78,
          "definition": "The process of submitting and updating summary information about the conclusions of a clinical study to a structured, publicly accessible, Web-based results database, such as the ClinicalTrials.gov results database. (clinicaltrials.gov)",
          "aliases": [
            "Results Submission"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3897271",
          "score": 0.779,
          "definition": "The outcome of the tumor results assessment as originally received or collected.",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C4704700",
          "score": 0.76,
          "definition": "Subject matter related to research studies in which the data do not demonstrate any clear evidence of effect, especially if an effect was expected.",
          "aliases": [
            "Negative Result",
            "Null Result",
            "Null Results"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_2",
      "canonical_id": "ent_3",
      "text": "raised",
      "label": "ENTITY",
      "start_char": 43,
      "end_char": 49,
      "sentence_text": "Mechanical biliary obstruction results in raised levels of ALP, GGT and often bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0442818",
          "score": 0.968,
          "definition": null,
          "aliases": [
            "Raised (qualifier value)",
            "Raised",
            "raised"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0178415",
          "score": 0.772,
          "definition": "The amount of prostate specific antigen is increased, based on pre-defined thresholds.",
          "aliases": [
            "Raised prostate specific antigen (finding)",
            "Elevated prostate specific antigen",
            "increased psa",
            "increasing psa",
            "PSA Elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0239984",
          "score": 0.772,
          "definition": "An abnormally increased level of immunoglobulin A in blood. [HPO:probinson]",
          "aliases": [
            "increased iga",
            "raised iga",
            "high immunoglobulins",
            "Increased serum IgA",
            "iga elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0234708",
          "score": 0.744,
          "definition": "Increased pressure of the intraocular fluid in the eye.",
          "aliases": [
            "INTRAOCULAR PRESSURE INCREASED",
            "TENSION OCULAR INCREASED",
            "INTRAOCULAR PRESSURE INCREASE",
            "PRESSURE INTRAOCULAR INCREASED",
            "raised intraocular pressure"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_3",
      "canonical_id": "ent_4",
      "text": "levels",
      "label": "ENTITY",
      "start_char": 50,
      "end_char": 56,
      "sentence_text": "Mechanical biliary obstruction results in raised levels of ALP, GGT and often bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0441889",
          "score": 0.988,
          "definition": "A position on a scale measuring intensity, quality, or amount.",
          "aliases": [
            "Level",
            "Levels",
            "levels",
            "Degree",
            "Levels (qualifier value)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0337439",
          "score": 0.797,
          "definition": "The determination of the amount of iron present in a sample.",
          "aliases": [
            "Iron level",
            "iron level test",
            "Iron measurement",
            "Iron Measurement",
            "iron levels"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0523459",
          "score": 0.769,
          "definition": "The determination of the amount of alanine present in a sample.",
          "aliases": [
            "Alanine Test",
            "Alanine measurement (procedure)",
            "Alanine measurement",
            "alanine level",
            "Alanine Measurement"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_4",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 60,
      "end_char": 63,
      "sentence_text": "Mechanical biliary obstruction results in raised levels of ALP, GGT and often bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_5",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 65,
      "end_char": 68,
      "sentence_text": "Mechanical biliary obstruction results in raised levels of ALP, GGT and often bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_6",
      "canonical_id": "ent_7",
      "text": "bilirubin",
      "label": "ENTITY",
      "start_char": 79,
      "end_char": 88,
      "sentence_text": "Mechanical biliary obstruction results in raised levels of ALP, GGT and often bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0005437",
          "score": 0.966,
          "definition": "A bile pigment that is a degradation product of HEME.",
          "aliases": [
            "21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-",
            "bilirubin",
            "Bilirubin, total",
            "Bilirubin",
            "Conjugated and unconjugated bilirubin"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5241078",
          "score": 0.966,
          "definition": null,
          "aliases": [
            "BILIRUBIN",
            "bilirubin preparation"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0182262",
          "score": 0.82,
          "definition": "Phototherapy units designed to irradiate newborns with visible light with a high component in the blue (typically from 420 to 480 nm wavelength) spectrum to treat hyperbilirubinemia (i.e., jaundice). The effect of this light is to convert water insoluble bilirubin to water-soluble photoproducts that are mostly excreted into bile. Hyperbilirubinemia phototherapy units are available as overhead units that apply the radiation directly from the lamp to the newborn and as separate light sources that deliver the light to the newborn through a fiberoptic cable and a transparent pad or blanket.",
          "aliases": [
            "Lights, Bilirubin",
            "Bilirubin Lamps",
            "bilirubin lights",
            "Bilirubin light",
            "phototherapy unit"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0201913",
          "score": 0.817,
          "definition": "The measurement of the total amount of bilirubin present in a particular substrate. The substrate most often tested is blood, but other fluids extracted from the body may be used periodically depending on the purpose of the test.",
          "aliases": [
            "Total bilirubin level",
            "bilirubin level test",
            "Total Bilirubin Measurement",
            "Total bilirubin",
            "Bilirubin, total measurement (procedure)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4764097",
          "score": 0.806,
          "definition": "The determination of the ratio of direct bilirubin compared to total bilirubin present in a sample. The measurement may be expressed as a ratio or percentage.",
          "aliases": [],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_7",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 90,
      "end_char": 93,
      "sentence_text": "ALP will usually be markedly raised in comparison with ALT.s Levels of ALP and GGT elevated in similar proportions signify a hepatobiliary source.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_8",
      "canonical_id": "ent_3",
      "text": "raised",
      "label": "ENTITY",
      "start_char": 119,
      "end_char": 125,
      "sentence_text": "ALP will usually be markedly raised in comparison with ALT.s Levels of ALP and GGT elevated in similar proportions signify a hepatobiliary source.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0442818",
          "score": 0.968,
          "definition": null,
          "aliases": [
            "Raised (qualifier value)",
            "Raised",
            "raised"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0178415",
          "score": 0.772,
          "definition": "The amount of prostate specific antigen is increased, based on pre-defined thresholds.",
          "aliases": [
            "Raised prostate specific antigen (finding)",
            "Elevated prostate specific antigen",
            "increased psa",
            "increasing psa",
            "PSA Elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0239984",
          "score": 0.772,
          "definition": "An abnormally increased level of immunoglobulin A in blood. [HPO:probinson]",
          "aliases": [
            "increased iga",
            "raised iga",
            "high immunoglobulins",
            "Increased serum IgA",
            "iga elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0234708",
          "score": 0.744,
          "definition": "Increased pressure of the intraocular fluid in the eye.",
          "aliases": [
            "INTRAOCULAR PRESSURE INCREASED",
            "TENSION OCULAR INCREASED",
            "INTRAOCULAR PRESSURE INCREASE",
            "PRESSURE INTRAOCULAR INCREASED",
            "raised intraocular pressure"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_9",
      "canonical_id": "ent_8",
      "text": "comparison",
      "label": "ENTITY",
      "start_char": 129,
      "end_char": 139,
      "sentence_text": "ALP will usually be markedly raised in comparison with ALT.s Levels of ALP and GGT elevated in similar proportions signify a hepatobiliary source.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C1707455",
          "score": 0.981,
          "definition": "The examination of two or more people or things in order to detect similarities and differences.",
          "aliases": [
            "Comparison",
            "Compare",
            "Compared"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1880097",
          "score": 0.806,
          "definition": "A type of analysis that determine the significance and/or magnitude of the difference between groups.",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C0871382",
          "score": 0.767,
          "definition": "Perception of one's abilities and attitudes in relation to those of others in a process that plays a significant role in self-image and subjective well-being.",
          "aliases": [
            "Comparison, Social",
            "Social Comparisons"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1579762",
          "score": 0.726,
          "definition": "A type of trial in which the drug of interest is compared against another drug or placebo.",
          "aliases": [
            "comparison study",
            "comparative study",
            "Comparative Study"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_10",
      "canonical_id": "ent_9",
      "text": "ALT.s\nLevels",
      "label": "ENTITY",
      "start_char": 145,
      "end_char": 157,
      "sentence_text": "ALP will usually be markedly raised in comparison with ALT.s Levels of ALP and GGT elevated in similar proportions signify a hepatobiliary source.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0441889",
          "score": 0.73,
          "definition": "A position on a scale measuring intensity, quality, or amount.",
          "aliases": [
            "Level",
            "Levels",
            "levels",
            "Degree",
            "Levels (qualifier value)"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_11",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 161,
      "end_char": 164,
      "sentence_text": "ALP will usually be markedly raised in comparison with ALT.s Levels of ALP and GGT elevated in similar proportions signify a hepatobiliary source.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_12",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 169,
      "end_char": 172,
      "sentence_text": "ALP will usually be markedly raised in comparison with ALT.s Levels of ALP and GGT elevated in similar proportions signify a hepatobiliary source.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_13",
      "canonical_id": "ent_10",
      "text": "elevated",
      "label": "ENTITY",
      "start_char": 173,
      "end_char": 181,
      "sentence_text": "ALP will usually be markedly raised in comparison with ALT.s Levels of ALP and GGT elevated in similar proportions signify a hepatobiliary source.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205250",
          "score": 0.978,
          "definition": "An elevated level or position or degree; greater than normal in degree or intensity or amount.",
          "aliases": [
            "High",
            "elevate",
            "Highly",
            "high",
            "elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3163633",
          "score": 0.978,
          "definition": "Raised or increased above normal levels or limits.",
          "aliases": [
            "Elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0520886",
          "score": 0.907,
          "definition": "An electrocardiographic finding of ST segment elevation above the baseline.",
          "aliases": [
            "ST SEGMENT ELEVATED",
            "st elevated",
            "elevation st",
            "st segment elevation",
            "st elevation ekg"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151904",
          "score": 0.863,
          "definition": "An increase in the level of aspartate aminotransferase in the blood.",
          "aliases": [
            "SGOT, ELEVATED",
            "ast elevated",
            "GLUTAMIC-OXALOACETIC TRANSAM INCR",
            "Elevated serum AST",
            "AST INCREASED"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0221106",
          "score": 0.856,
          "definition": "An abnormally high blood pH (usually defined as 7.41 or above). [PMID:24381489]",
          "aliases": [
            "increase ph",
            "Acid deficit",
            "Baseosis",
            "increasing ph",
            "ELEVATED PH"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_14",
      "canonical_id": "ent_11",
      "text": "proportions",
      "label": "ENTITY",
      "start_char": 193,
      "end_char": 204,
      "sentence_text": "ALP will usually be markedly raised in comparison with ALT.s Levels of ALP and GGT elevated in similar proportions signify a hepatobiliary source.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C1709707",
          "score": 0.858,
          "definition": "A part, fraction, share, or number considered in relation to the whole amount or number.",
          "aliases": [],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_15",
      "canonical_id": "ent_12",
      "text": "enzyme",
      "label": "ENTITY",
      "start_char": 276,
      "end_char": 282,
      "sentence_text": "Otherwise alternative causes of single enzyme elevation should be considered.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0014442",
          "score": 0.985,
          "definition": "Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.",
          "aliases": [
            "Enzymes (see also Inborn errors metabolism lysosomal)",
            "Biocatalyst",
            "Substance with enzyme mechanism of action (substance)",
            "Enzymes",
            "Enzyme"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4521602",
          "score": 0.985,
          "definition": null,
          "aliases": [
            "Enzyme (disposition)",
            "Enzyme"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5399708",
          "score": 0.985,
          "definition": null,
          "aliases": [
            "Enzyme",
            "Enzyme [APC]"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0027203",
          "score": 0.917,
          "definition": "An autolytic enzyme bound to the surface of bacterial cell walls. It catalyzes the hydrolysis of the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell wall glycopeptides, particularly peptidoglycan. EC 3.5.1.28.",
          "aliases": [
            "Hydrolase, Murein",
            "N-Acetylmuramoyl-L-alanine amidase",
            "N-Acetylmuramoyl-L-alanine Amidase",
            "Peptidoglycan amidohydrolase",
            "N Acetylmuramoyl L alanine Amidase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2248828",
          "score": 0.868,
          "definition": "Catalysis of the acetylation of residue Lys609 of the enzyme acetyl-CoA synthetase, using acetyl-CoA as substrate. [PMID:15236963]",
          "aliases": [
            "Pat enzyme"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_16",
      "canonical_id": "ent_13",
      "text": "choledocholithiasis",
      "label": "ENTITY",
      "start_char": 327,
      "end_char": 346,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0701818",
          "score": 0.989,
          "definition": "Presence or formation of GALLSTONES in the COMMON BILE DUCT.",
          "aliases": [
            "choledocholithiasis",
            "Choledocholithiasis",
            "CHOLEDOCHOLITHIASIS",
            "Cholelithiasis, Common Bile Duct"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0008350",
          "score": 0.75,
          "definition": "Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).",
          "aliases": [
            "Gallstone Diseases",
            "Calculus in biliary tract",
            "Calculus in biliary tract (disorder)",
            "GALLSTONES",
            "calculus of gallbladder"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0856727",
          "score": 0.729,
          "definition": "Gallstones composed primarily of cholesterol, usually about 2-3 cm in length with an oval form and a yellow or green/brown color. [HPO:probinson, PMID:12950109, PMID:16844493]",
          "aliases": [
            "Cholesterol gallstones",
            "cholesterol gallstones",
            "Cholesterol cholelithiasis",
            "cholesterol gallstone"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0267853",
          "score": 0.702,
          "definition": "An acute or chronic inflammation of the gallbladder associated with the presence of gallstones.",
          "aliases": [
            "Calculus of gallbladder with cholecystitis (disorder)",
            "cholecystitis cholelithiasis",
            "Cholelithiasis with cholecystitis, NOS",
            "Cholecystitis with Cholelithiasis",
            "cholelithiasis cholecystitis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_17",
      "canonical_id": "ent_4",
      "text": "levels",
      "label": "ENTITY",
      "start_char": 352,
      "end_char": 358,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0441889",
          "score": 0.988,
          "definition": "A position on a scale measuring intensity, quality, or amount.",
          "aliases": [
            "Level",
            "Levels",
            "levels",
            "Degree",
            "Levels (qualifier value)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0337439",
          "score": 0.797,
          "definition": "The determination of the amount of iron present in a sample.",
          "aliases": [
            "Iron level",
            "iron level test",
            "Iron measurement",
            "Iron Measurement",
            "iron levels"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0523459",
          "score": 0.769,
          "definition": "The determination of the amount of alanine present in a sample.",
          "aliases": [
            "Alanine Test",
            "Alanine measurement (procedure)",
            "Alanine measurement",
            "alanine level",
            "Alanine Measurement"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_18",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 362,
      "end_char": 365,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_19",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 370,
      "end_char": 373,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_20",
      "canonical_id": "ent_14",
      "text": "fluctuate",
      "label": "ENTITY",
      "start_char": 382,
      "end_char": 391,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0231241",
          "score": 0.98,
          "definition": "To be unstable, having ups and downs.",
          "aliases": [
            "Fluctuate",
            "Fluctuating (qualifier value)",
            "Fluctuating",
            "fluctuated",
            "Fluctuation"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_21",
      "canonical_id": "ent_8",
      "text": "comparison",
      "label": "ENTITY",
      "start_char": 396,
      "end_char": 406,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C1707455",
          "score": 0.981,
          "definition": "The examination of two or more people or things in order to detect similarities and differences.",
          "aliases": [
            "Comparison",
            "Compare",
            "Compared"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1880097",
          "score": 0.806,
          "definition": "A type of analysis that determine the significance and/or magnitude of the difference between groups.",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C0871382",
          "score": 0.767,
          "definition": "Perception of one's abilities and attitudes in relation to those of others in a process that plays a significant role in self-image and subjective well-being.",
          "aliases": [
            "Comparison, Social",
            "Social Comparisons"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1579762",
          "score": 0.726,
          "definition": "A type of trial in which the drug of interest is compared against another drug or placebo.",
          "aliases": [
            "comparison study",
            "comparative study",
            "Comparative Study"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_22",
      "canonical_id": "ent_15",
      "text": "stricture forming disease",
      "label": "ENTITY",
      "start_char": 410,
      "end_char": 435,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_23",
      "canonical_id": "ent_16",
      "text": "associated with",
      "label": "ENTITY",
      "start_char": 448,
      "end_char": 463,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0332281",
          "score": 0.989,
          "definition": "Joined in some kind of relationship.",
          "aliases": [
            "AW",
            "associating",
            "Associated with (attribute)",
            "associated with",
            "Associated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1428063",
          "score": 0.754,
          "definition": "This gene may play a role in both ubiquitination and transcriptional regulation.",
          "aliases": [
            "MYCBP2",
            "PROTEIN ASSOCIATED WITH MYC",
            "MYCBP2 gene",
            "KIAA0916",
            "FLJ10106"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2982406",
          "score": 0.754,
          "definition": "Probable E3 ubiquitin-protein ligase MYCBP2 (4640 aa, ~510 kDa) is encoded by the human MYCBP2 gene. This protein may play a role in both the mediation of ubiquitination and the regulation of transcription.",
          "aliases": [
            "Probable E3 Ubiquitin-Protein Ligase MYCBP2",
            "Pam/Highwire/Rpm-1 Protein",
            "Myc-Binding Protein 2",
            "Protein Associated With Myc"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0271175",
          "score": 0.728,
          "definition": "A cataract resulting from exposure to radiation.",
          "aliases": [
            "radiation cataract",
            "Radiation-Induced Cataract",
            "cataract radiation",
            "Radiation cataract",
            "cataracts radiation"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1505125",
          "score": 0.722,
          "definition": "GTP-binding protein RAD (308 aa, ~33 kDa) is encoded by the human RRAD gene. This protein is involved in the regulation of calmodulin- and voltage-dependent L-type calcium channel subunit alpha-1C-mediated signaling.",
          "aliases": [
            "RRAD protein, human",
            "Ras-related associated with diabetes protein, human",
            "RAD Protein",
            "Ras-Related Associated with Diabetes Protein",
            "RAD"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "POSSIBLE_EXISTENCE",
          "trigger_phrase": "may be associated",
          "direction": "FORWARD",
          "scope_phrase": "associated with a normal bilirubin.\nEnzyme"
        }
      ]
    },
    {
      "instance_id": "inst_24",
      "canonical_id": "ent_17",
      "text": "normal",
      "label": "ENTITY",
      "start_char": 466,
      "end_char": 472,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205307",
          "score": 0.98,
          "definition": "In pathology, a term that is used to describe a tissue specimen that has a normal appearance.",
          "aliases": [
            "Normal (qualifier value)",
            "unremarkable",
            "normal",
            "Unremarkable",
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1550457",
          "score": 0.98,
          "definition": "<p>The result or observation value is within the reference range or expected norm (as defined for the respective test procedure).</p><p>\\[Note: Applies to numeric or non-numeric results.\\]</p>",
          "aliases": [
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1550469",
          "score": 0.98,
          "definition": "<p>Privacy metadata indicating the level of protection required to safeguard personal and healthcare information, which if disclosed without authorization, would present a considerable risk of harm to an individual's reputation and sense of privacy.</p><i>Usage Note:</i>The level of protection afforded normatively confidential information is dictated by the prevailing normative privacy policies, which are intended to engender patient trust in their healthcare providers.<p>Privacy policies mandating normative levels of protection, which preempt less protective privacy policies when the information is used in the delivery and management of healthcare. May be pre-empted by jurisdictional law (e.g., for public health reporting or emergency treatment).</p><p>Confidentiality code total order hierarchy: Normal (N) is less protective than *V* and *R*, and subsumes all other protection levels (i.e., *M, L, and U*).</p><p>**Map:**Partial Map to ISO 13606-4 Sensitivity Level (3) Clinical Care when purpose of use is treatment: Default for normal clinical care access (i.e., most clinical staff directly caring for the patient should be able to access nearly all of the EHR). Maps to normal confidentiality for treatment information but not to ancillary care, payment and operations.</p><b>Examples:</b><p>n the US, this includes what HIPAA identifies as protected health information (PHI) under 45 CFR Section 160.103.</p>",
          "aliases": [
            "normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1551394",
          "score": 0.98,
          "definition": "<p>No Corrective Action Needed</p>",
          "aliases": [
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1553386",
          "score": 0.98,
          "definition": "<p>Encompasses the expected states of an Act, but excludes \"nullified\" and \"obsolete\" which represent unusual terminal states for the life-cycle.</p>",
          "aliases": [
            "normal"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "POSSIBLE_EXISTENCE",
          "trigger_phrase": "may be associated",
          "direction": "FORWARD",
          "scope_phrase": "associated with a normal bilirubin.\nEnzyme"
        }
      ]
    },
    {
      "instance_id": "inst_25",
      "canonical_id": "ent_7",
      "text": "bilirubin",
      "label": "ENTITY",
      "start_char": 473,
      "end_char": 482,
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0005437",
          "score": 0.966,
          "definition": "A bile pigment that is a degradation product of HEME.",
          "aliases": [
            "21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-",
            "bilirubin",
            "Bilirubin, total",
            "Bilirubin",
            "Conjugated and unconjugated bilirubin"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5241078",
          "score": 0.966,
          "definition": null,
          "aliases": [
            "BILIRUBIN",
            "bilirubin preparation"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0182262",
          "score": 0.82,
          "definition": "Phototherapy units designed to irradiate newborns with visible light with a high component in the blue (typically from 420 to 480 nm wavelength) spectrum to treat hyperbilirubinemia (i.e., jaundice). The effect of this light is to convert water insoluble bilirubin to water-soluble photoproducts that are mostly excreted into bile. Hyperbilirubinemia phototherapy units are available as overhead units that apply the radiation directly from the lamp to the newborn and as separate light sources that deliver the light to the newborn through a fiberoptic cable and a transparent pad or blanket.",
          "aliases": [
            "Lights, Bilirubin",
            "Bilirubin Lamps",
            "bilirubin lights",
            "Bilirubin light",
            "phototherapy unit"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0201913",
          "score": 0.817,
          "definition": "The measurement of the total amount of bilirubin present in a particular substrate. The substrate most often tested is blood, but other fluids extracted from the body may be used periodically depending on the purpose of the test.",
          "aliases": [
            "Total bilirubin level",
            "bilirubin level test",
            "Total Bilirubin Measurement",
            "Total bilirubin",
            "Bilirubin, total measurement (procedure)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4764097",
          "score": 0.806,
          "definition": "The determination of the ratio of direct bilirubin compared to total bilirubin present in a sample. The measurement may be expressed as a ratio or percentage.",
          "aliases": [],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "POSSIBLE_EXISTENCE",
          "trigger_phrase": "may be associated",
          "direction": "FORWARD",
          "scope_phrase": "associated with a normal bilirubin.\nEnzyme"
        }
      ]
    },
    {
      "instance_id": "inst_26",
      "canonical_id": "ent_12",
      "text": "Enzyme",
      "label": "ENTITY",
      "start_char": 484,
      "end_char": 490,
      "sentence_text": "Enzyme titres tend to rise and fall gradually and may be preceded by a peaked rise in liver transaminases which can reach > 1000I/U.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0014442",
          "score": 0.985,
          "definition": "Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.",
          "aliases": [
            "Enzymes (see also Inborn errors metabolism lysosomal)",
            "Biocatalyst",
            "Substance with enzyme mechanism of action (substance)",
            "Enzymes",
            "Enzyme"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4521602",
          "score": 0.985,
          "definition": null,
          "aliases": [
            "Enzyme (disposition)",
            "Enzyme"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5399708",
          "score": 0.985,
          "definition": null,
          "aliases": [
            "Enzyme",
            "Enzyme [APC]"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0027203",
          "score": 0.917,
          "definition": "An autolytic enzyme bound to the surface of bacterial cell walls. It catalyzes the hydrolysis of the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell wall glycopeptides, particularly peptidoglycan. EC 3.5.1.28.",
          "aliases": [
            "Hydrolase, Murein",
            "N-Acetylmuramoyl-L-alanine amidase",
            "N-Acetylmuramoyl-L-alanine Amidase",
            "Peptidoglycan amidohydrolase",
            "N Acetylmuramoyl L alanine Amidase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2248828",
          "score": 0.868,
          "definition": "Catalysis of the acetylation of residue Lys609 of the enzyme acetyl-CoA synthetase, using acetyl-CoA as substrate. [PMID:15236963]",
          "aliases": [
            "Pat enzyme"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_27",
      "canonical_id": "ent_18",
      "text": "titres",
      "label": "ENTITY",
      "start_char": 491,
      "end_char": 497,
      "sentence_text": "Enzyme titres tend to rise and fall gradually and may be preceded by a peaked rise in liver transaminases which can reach > 1000I/U.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0475208",
          "score": 0.744,
          "definition": "Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.",
          "aliases": [
            "Dilution factor expressed as titer (property) (qualifier value)",
            "Dilution factor expressed as titer (property)",
            "Titer",
            "Titre",
            "*Dilution Factor (Titer)"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_28",
      "canonical_id": "ent_19",
      "text": "fall",
      "label": "ENTITY",
      "start_char": 515,
      "end_char": 519,
      "sentence_text": "Enzyme titres tend to rise and fall gradually and may be preceded by a peaked rise in liver transaminases which can reach > 1000I/U.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0085639",
          "score": 0.982,
          "definition": "A sudden movement downward, usually resulting in injury.",
          "aliases": [
            "fall down",
            "fall",
            "Fall (event)",
            "fall injury",
            "FALLING DOWN"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0238715",
          "score": 0.982,
          "definition": "The season between the autumnal equinox and the winter solstice.",
          "aliases": [
            "AUTUMN",
            "autumn",
            "Autumn",
            "Fall",
            "fall or autumn"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_29",
      "canonical_id": "ent_20",
      "text": "liver transaminases",
      "label": "ENTITY",
      "start_char": 570,
      "end_char": 589,
      "sentence_text": "Enzyme titres tend to rise and fall gradually and may be preceded by a peaked rise in liver transaminases which can reach > 1000I/U.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002594",
          "score": 0.824,
          "definition": "A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.",
          "aliases": [
            "aminotransferase",
            "Aminotransferases",
            "Transaminases",
            "transaminases",
            "Substance with aminotransferase mechanism of action (substance)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1848701",
          "score": 0.786,
          "definition": "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage. [HPO:probinson]",
          "aliases": [
            "Elevated liver transaminases",
            "Elevated hepatic transaminases"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0002484",
          "score": 0.713,
          "definition": "Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4.",
          "aliases": [
            "amidinotransferase",
            "Transamidinases",
            "Amidinotransferase",
            "Transamidinase",
            "Amidinotransferases"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0004002",
          "score": 0.709,
          "definition": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.",
          "aliases": [
            "s-asat",
            "Glutamic oxaloacetic transaminase (GOT)",
            "Aspartate Aminotransferases",
            "glutamic oxaloacetic transaminase",
            "Glutamic Oxaloacetic Transaminase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4507520",
          "score": 0.709,
          "definition": "Aspartate aminotransferase, cytoplasmic (413 aa, ~46 kDa) is encoded by the human GOT1 gene. This protein is involved in amino acid metabolism.",
          "aliases": [
            "GOT1 protein, human",
            "Soluble Glutamic-Oxaloacetic Transaminase 1",
            "Transaminase A",
            "Glutamate Oxaloacetate Transaminase-1",
            "Aspartate Aminotransferase, Cytoplasmic"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "POSSIBLE_EXISTENCE",
          "trigger_phrase": "may be preceded",
          "direction": "FORWARD",
          "scope_phrase": "preceded by a peaked rise in liver transaminases which can reach > 1000I/U.\nThe"
        }
      ]
    },
    {
      "instance_id": "inst_30",
      "canonical_id": "ent_21",
      "text": "U.\n",
      "label": "ENTITY",
      "start_char": 614,
      "end_char": 617,
      "sentence_text": "Enzyme titres tend to rise and fall gradually and may be preceded by a peaked rise in liver transaminases which can reach > 1000I/U.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [],
      "contextual_modifiers": [
        {
          "category": "POSSIBLE_EXISTENCE",
          "trigger_phrase": "may be preceded",
          "direction": "FORWARD",
          "scope_phrase": "preceded by a peaked rise in liver transaminases which can reach > 1000I/U.\nThe"
        }
      ]
    },
    {
      "instance_id": "inst_31",
      "canonical_id": "ent_22",
      "text": "AST",
      "label": "ENTITY",
      "start_char": 621,
      "end_char": 624,
      "sentence_text": "The AST:ALT ratio (De Ritis ratio) may assist in differentiating the site of biliary obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0004002",
          "score": 0.998,
          "definition": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.",
          "aliases": [
            "s-asat",
            "Glutamic oxaloacetic transaminase (GOT)",
            "Aspartate Aminotransferases",
            "glutamic oxaloacetic transaminase",
            "Glutamic Oxaloacetic Transaminase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415181",
          "score": 0.998,
          "definition": "This gene plays a role in amino acid metabolism, the tricarboxylic acid cycle and the urea cycle.",
          "aliases": [
            "glutamate oxaloacetate transaminase 1",
            "glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)",
            "GOT1 Gene",
            "GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE",
            "glutamic-oxaloacetic transaminase 1"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1420113",
          "score": 0.998,
          "definition": null,
          "aliases": [
            "sialic acid storage disease",
            "SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5",
            "NSD",
            "solute carrier family 17 member 5",
            "SIASD"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724380",
          "score": 0.998,
          "definition": "A West Iberian Romance language spoken in the Principality of Asturias, Spain.",
          "aliases": [
            "AST",
            "Asturian Language",
            "Bable",
            "Asturian"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_32",
      "canonical_id": "ent_23",
      "text": "ALT ratio",
      "label": "ENTITY",
      "start_char": 625,
      "end_char": 634,
      "sentence_text": "The AST:ALT ratio (De Ritis ratio) may assist in differentiating the site of biliary obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0456603",
          "score": 0.766,
          "definition": "Quotient of quantities of the same kind for different components within the same system.",
          "aliases": [
            "ratios",
            "Ratios",
            "Ratio (property) (qualifier value)",
            "RATIO",
            "Ratio"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_33",
      "canonical_id": "ent_24",
      "text": "De Ritis ratio",
      "label": "ENTITY",
      "start_char": 636,
      "end_char": 650,
      "sentence_text": "The AST:ALT ratio (De Ritis ratio) may assist in differentiating the site of biliary obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_34",
      "canonical_id": "ent_25",
      "text": "site",
      "label": "ENTITY",
      "start_char": 686,
      "end_char": 690,
      "sentence_text": "The AST:ALT ratio (De Ritis ratio) may assist in differentiating the site of biliary obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205145",
          "score": 0.993,
          "definition": "A position in relation to its surroundings.",
          "aliases": [
            "Sites",
            "Site (attribute)",
            "Site"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1515974",
          "score": 0.993,
          "definition": "Named locations of or within the body.",
          "aliases": [
            "Location",
            "Anatomic Site",
            "Anatomic Sites",
            "Site",
            "Anatomic Location"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1546778",
          "score": 0.993,
          "definition": null,
          "aliases": [
            "Site"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2825164",
          "score": 0.993,
          "definition": "A facility in which study/protocol activities are conducted.",
          "aliases": [
            "Investigative Site",
            "Investigator Site",
            "Site",
            "Study Site"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2827983",
          "score": 0.731,
          "definition": "Any healthcare organization, institution, facility or provider directly involved in conducting or facilitating a particular clinical trial.",
          "aliases": [
            "Trial Site",
            "Clinical Trial Site"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_35",
      "canonical_id": "ent_26",
      "text": "biliary obstruction",
      "label": "ENTITY",
      "start_char": 694,
      "end_char": 713,
      "sentence_text": "The AST:ALT ratio (De Ritis ratio) may assist in differentiating the site of biliary obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0400979",
          "score": 0.977,
          "definition": "Blockage in the biliary tract that carries bile from the liver to the gallbladder and small intestine. Causes include gallstones, biliary tract strictures and inflammation, pancreatitis, cirrhosis, lymph node enlargement, and bile duct and pancreas neoplasms.",
          "aliases": [
            "Biliary Obstruction",
            "biliary tract obstruction",
            "Obstruction of biliary tree (disorder)",
            "biliary obstruction",
            "biliary obstructions"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3898473",
          "score": 0.79,
          "definition": "Blockage in the biliary tract caused by a malignant neoplasm.",
          "aliases": [
            "malignant biliary obstruction"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0008370",
          "score": 0.76,
          "definition": "Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).",
          "aliases": [
            "obstruction bile duct",
            "Obstruction of bile duct, NOS",
            "Occlusion of bile duct, NOS",
            "bile stasis",
            "Obstruction of bile duct (disorder)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0028778",
          "score": 0.759,
          "definition": "Blockage of the normal flow of the contents of an anatomical passageway.",
          "aliases": [
            "occluded",
            "Obstruction, NOS",
            "OBSTRUCTIONS",
            "blocked",
            "blocks"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0005398",
          "score": 0.721,
          "definition": "Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes.",
          "aliases": [
            "Extrahepatic cholestasis",
            "cholestasis extrahepatic",
            "Biliary Stasis, Extrahepatic",
            "extrahepatic cholestasis",
            "Extrahepatic Bile Duct Obstruction"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_36",
      "canonical_id": "ent_16",
      "text": "associated with",
      "label": "ENTITY",
      "start_char": 720,
      "end_char": 735,
      "sentence_text": "When associated with a cholestatic picture, an AST:ALT ratio of <1.5 suggests an extrahepatic obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0332281",
          "score": 0.989,
          "definition": "Joined in some kind of relationship.",
          "aliases": [
            "AW",
            "associating",
            "Associated with (attribute)",
            "associated with",
            "Associated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1428063",
          "score": 0.754,
          "definition": "This gene may play a role in both ubiquitination and transcriptional regulation.",
          "aliases": [
            "MYCBP2",
            "PROTEIN ASSOCIATED WITH MYC",
            "MYCBP2 gene",
            "KIAA0916",
            "FLJ10106"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2982406",
          "score": 0.754,
          "definition": "Probable E3 ubiquitin-protein ligase MYCBP2 (4640 aa, ~510 kDa) is encoded by the human MYCBP2 gene. This protein may play a role in both the mediation of ubiquitination and the regulation of transcription.",
          "aliases": [
            "Probable E3 Ubiquitin-Protein Ligase MYCBP2",
            "Pam/Highwire/Rpm-1 Protein",
            "Myc-Binding Protein 2",
            "Protein Associated With Myc"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0271175",
          "score": 0.728,
          "definition": "A cataract resulting from exposure to radiation.",
          "aliases": [
            "radiation cataract",
            "Radiation-Induced Cataract",
            "cataract radiation",
            "Radiation cataract",
            "cataracts radiation"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1505125",
          "score": 0.722,
          "definition": "GTP-binding protein RAD (308 aa, ~33 kDa) is encoded by the human RRAD gene. This protein is involved in the regulation of calmodulin- and voltage-dependent L-type calcium channel subunit alpha-1C-mediated signaling.",
          "aliases": [
            "RRAD protein, human",
            "Ras-related associated with diabetes protein, human",
            "RAD Protein",
            "Ras-Related Associated with Diabetes Protein",
            "RAD"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_37",
      "canonical_id": "ent_27",
      "text": "cholestatic picture",
      "label": "ENTITY",
      "start_char": 738,
      "end_char": 757,
      "sentence_text": "When associated with a cholestatic picture, an AST:ALT ratio of <1.5 suggests an extrahepatic obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_38",
      "canonical_id": "ent_22",
      "text": "AST",
      "label": "ENTITY",
      "start_char": 762,
      "end_char": 765,
      "sentence_text": "When associated with a cholestatic picture, an AST:ALT ratio of <1.5 suggests an extrahepatic obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0004002",
          "score": 0.998,
          "definition": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.",
          "aliases": [
            "s-asat",
            "Glutamic oxaloacetic transaminase (GOT)",
            "Aspartate Aminotransferases",
            "glutamic oxaloacetic transaminase",
            "Glutamic Oxaloacetic Transaminase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415181",
          "score": 0.998,
          "definition": "This gene plays a role in amino acid metabolism, the tricarboxylic acid cycle and the urea cycle.",
          "aliases": [
            "glutamate oxaloacetate transaminase 1",
            "glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)",
            "GOT1 Gene",
            "GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE",
            "glutamic-oxaloacetic transaminase 1"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1420113",
          "score": 0.998,
          "definition": null,
          "aliases": [
            "sialic acid storage disease",
            "SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5",
            "NSD",
            "solute carrier family 17 member 5",
            "SIASD"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724380",
          "score": 0.998,
          "definition": "A West Iberian Romance language spoken in the Principality of Asturias, Spain.",
          "aliases": [
            "AST",
            "Asturian Language",
            "Bable",
            "Asturian"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_39",
      "canonical_id": "ent_28",
      "text": "ALT",
      "label": "ENTITY",
      "start_char": 766,
      "end_char": 769,
      "sentence_text": "When associated with a cholestatic picture, an AST:ALT ratio of <1.5 suggests an extrahepatic obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0001899",
          "score": 0.991,
          "definition": "An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.",
          "aliases": [
            "alanine transaminase",
            "transaminase glutamic-pyruvic",
            "Glutamate pyruvate transaminase",
            "ALAT - alanine aminotransferase",
            "Transaminase, Glutamic-Pyruvic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1370889",
          "score": 0.991,
          "definition": "An atypical lipomatous tumor/well differentiated liposarcoma composed of mature adipocytes in which, unlike in benign lipoma, substantial variation in cell size is appreciated alongside nuclear atypia in fat cells or stromal spindle cells. (WHO 2020)",
          "aliases": [
            "Atypical Lipomatous Tumors",
            "Lipomatous Tumor, Atypical",
            "Liposarcoma, well differentiated (morphologic abnormality)",
            "Atypical lipoma",
            "ALT"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2257651",
          "score": 0.991,
          "definition": "Catalysis of the reaction: 2-oxoglutarate + L-alanine = L-glutamate + pyruvate. [EC:2.6.1.2, RHEA:19453]",
          "aliases": [
            "alanine aminotransferase activity",
            "GPT",
            "glutamic acid-pyruvic acid transaminase activity",
            "pyruvate-alanine aminotransferase activity",
            "glutamic-pyruvic aminotransferase activity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4553172",
          "score": 0.991,
          "definition": "The use of a highly concentrated antibiotic solution for the to treatment of catheter-related bloodstream infections.",
          "aliases": [
            "Antibiotic Lock Therapy",
            "ALT"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724507",
          "score": 0.991,
          "definition": "A Turkic language, spoken officially in the Altai Republic of Russia.",
          "aliases": [
            "Gorno-Altay",
            "Southern Altai Language",
            "Gorno-Altai",
            "ALT",
            "Southern Altai"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_40",
      "canonical_id": "ent_29",
      "text": "ratio",
      "label": "ENTITY",
      "start_char": 770,
      "end_char": 775,
      "sentence_text": "When associated with a cholestatic picture, an AST:ALT ratio of <1.5 suggests an extrahepatic obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0456603",
          "score": 0.968,
          "definition": "Quotient of quantities of the same kind for different components within the same system.",
          "aliases": [
            "ratios",
            "Ratios",
            "Ratio (property) (qualifier value)",
            "RATIO",
            "Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5447121",
          "score": 0.738,
          "definition": "The ratio of two concentration values.",
          "aliases": [
            "Ratio Concentration"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264679",
          "score": 0.736,
          "definition": "The quotient of the mass concentration of one substance divided by the mass concentration of another substance within the same system.",
          "aliases": [
            "Mass ratio (property)",
            "MRTO",
            "Mass ratio (property) (qualifier value)",
            "Mass Ratio",
            "*Mass Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264675",
          "score": 0.706,
          "definition": "The ratio of the length of time for one event and the length of time for another event.",
          "aliases": [
            "TRTO",
            "Time Ratio",
            "Time ratio (property) (qualifier value)",
            "Time ratio (property)",
            "TRto"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_41",
      "canonical_id": "ent_30",
      "text": "extrahepatic obstruction",
      "label": "ENTITY",
      "start_char": 796,
      "end_char": 820,
      "sentence_text": "When associated with a cholestatic picture, an AST:ALT ratio of <1.5 suggests an extrahepatic obstruction.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0005398",
          "score": 0.847,
          "definition": "Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes.",
          "aliases": [
            "Extrahepatic cholestasis",
            "cholestasis extrahepatic",
            "Biliary Stasis, Extrahepatic",
            "extrahepatic cholestasis",
            "Extrahepatic Bile Duct Obstruction"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0019154",
          "score": 0.737,
          "definition": "An obstruction in the veins of the liver caused by a blood clot (thrombosis). [HPO:probinson]",
          "aliases": [
            "budd chiari's syndrome",
            "chiari's syndrome",
            "Hepatic vein thrombosis (disorder)",
            "Hepatic Vein Thrombosis",
            "budd chiari syndrome"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0008372",
          "score": 0.709,
          "definition": "Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).",
          "aliases": [
            "Cholestasis, Intrahepatic",
            "CHOLESTASIS INTRAHEPATIC",
            "Bile Duct Obstruction, Intrahepatic",
            "Intrahepatic Biliary Stasis",
            "Intrahepatic Biliary Stases"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_42",
      "canonical_id": "ent_31",
      "text": "ALT titre",
      "label": "ENTITY",
      "start_char": 848,
      "end_char": 857,
      "sentence_text": "In such circumstances the ALT titre is frequently considerably higher than AST.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0475208",
          "score": 0.787,
          "definition": "Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.",
          "aliases": [
            "Dilution factor expressed as titer (property) (qualifier value)",
            "Dilution factor expressed as titer (property)",
            "Titer",
            "Titre",
            "*Dilution Factor (Titer)"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_43",
      "canonical_id": "ent_32",
      "text": "higher",
      "label": "ENTITY",
      "start_char": 885,
      "end_char": 891,
      "sentence_text": "In such circumstances the ALT titre is frequently considerably higher than AST.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205250",
          "score": 0.947,
          "definition": "An elevated level or position or degree; greater than normal in degree or intensity or amount.",
          "aliases": [
            "High",
            "elevate",
            "Highly",
            "high",
            "elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0682475",
          "score": 0.791,
          "definition": "A subset of plants bearing a vascular system. Examples are ferns and seed-bearing species.",
          "aliases": [
            "Tracheophytes",
            "Vascular plants",
            "tracheophytes",
            "Pteridophyta",
            "vascular plants <common name>"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1562025",
          "score": 0.737,
          "definition": "Higher plants that live primarily in terrestrial habitats, although some are secondarily aquatic. Most obtain their energy from PHOTOSYNTHESIS. They comprise the vascular and non-vascular plants.",
          "aliases": [
            "Land Plants",
            "Plants, Land",
            "Plant, Land",
            "Phylum Embryophyta",
            "land plants <common name>"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_44",
      "canonical_id": "ent_22",
      "text": "AST",
      "label": "ENTITY",
      "start_char": 897,
      "end_char": 900,
      "sentence_text": "In such circumstances the ALT titre is frequently considerably higher than AST.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0004002",
          "score": 0.998,
          "definition": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.",
          "aliases": [
            "s-asat",
            "Glutamic oxaloacetic transaminase (GOT)",
            "Aspartate Aminotransferases",
            "glutamic oxaloacetic transaminase",
            "Glutamic Oxaloacetic Transaminase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415181",
          "score": 0.998,
          "definition": "This gene plays a role in amino acid metabolism, the tricarboxylic acid cycle and the urea cycle.",
          "aliases": [
            "glutamate oxaloacetate transaminase 1",
            "glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)",
            "GOT1 Gene",
            "GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE",
            "glutamic-oxaloacetic transaminase 1"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1420113",
          "score": 0.998,
          "definition": null,
          "aliases": [
            "sialic acid storage disease",
            "SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5",
            "NSD",
            "solute carrier family 17 member 5",
            "SIASD"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724380",
          "score": 0.998,
          "definition": "A West Iberian Romance language spoken in the Principality of Asturias, Spain.",
          "aliases": [
            "AST",
            "Asturian Language",
            "Bable",
            "Asturian"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_45",
      "canonical_id": "ent_22",
      "text": "AST",
      "label": "ENTITY",
      "start_char": 905,
      "end_char": 908,
      "sentence_text": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0004002",
          "score": 0.998,
          "definition": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.",
          "aliases": [
            "s-asat",
            "Glutamic oxaloacetic transaminase (GOT)",
            "Aspartate Aminotransferases",
            "glutamic oxaloacetic transaminase",
            "Glutamic Oxaloacetic Transaminase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415181",
          "score": 0.998,
          "definition": "This gene plays a role in amino acid metabolism, the tricarboxylic acid cycle and the urea cycle.",
          "aliases": [
            "glutamate oxaloacetate transaminase 1",
            "glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)",
            "GOT1 Gene",
            "GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE",
            "glutamic-oxaloacetic transaminase 1"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1420113",
          "score": 0.998,
          "definition": null,
          "aliases": [
            "sialic acid storage disease",
            "SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5",
            "NSD",
            "solute carrier family 17 member 5",
            "SIASD"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724380",
          "score": 0.998,
          "definition": "A West Iberian Romance language spoken in the Principality of Asturias, Spain.",
          "aliases": [
            "AST",
            "Asturian Language",
            "Bable",
            "Asturian"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "likely.\n",
          "direction": "BACKWARD",
          "scope_phrase": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely"
        }
      ]
    },
    {
      "instance_id": "inst_46",
      "canonical_id": "ent_28",
      "text": "ALT",
      "label": "ENTITY",
      "start_char": 909,
      "end_char": 912,
      "sentence_text": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0001899",
          "score": 0.991,
          "definition": "An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.",
          "aliases": [
            "alanine transaminase",
            "transaminase glutamic-pyruvic",
            "Glutamate pyruvate transaminase",
            "ALAT - alanine aminotransferase",
            "Transaminase, Glutamic-Pyruvic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1370889",
          "score": 0.991,
          "definition": "An atypical lipomatous tumor/well differentiated liposarcoma composed of mature adipocytes in which, unlike in benign lipoma, substantial variation in cell size is appreciated alongside nuclear atypia in fat cells or stromal spindle cells. (WHO 2020)",
          "aliases": [
            "Atypical Lipomatous Tumors",
            "Lipomatous Tumor, Atypical",
            "Liposarcoma, well differentiated (morphologic abnormality)",
            "Atypical lipoma",
            "ALT"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2257651",
          "score": 0.991,
          "definition": "Catalysis of the reaction: 2-oxoglutarate + L-alanine = L-glutamate + pyruvate. [EC:2.6.1.2, RHEA:19453]",
          "aliases": [
            "alanine aminotransferase activity",
            "GPT",
            "glutamic acid-pyruvic acid transaminase activity",
            "pyruvate-alanine aminotransferase activity",
            "glutamic-pyruvic aminotransferase activity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4553172",
          "score": 0.991,
          "definition": "The use of a highly concentrated antibiotic solution for the to treatment of catheter-related bloodstream infections.",
          "aliases": [
            "Antibiotic Lock Therapy",
            "ALT"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724507",
          "score": 0.991,
          "definition": "A Turkic language, spoken officially in the Altai Republic of Russia.",
          "aliases": [
            "Gorno-Altay",
            "Southern Altai Language",
            "Gorno-Altai",
            "ALT",
            "Southern Altai"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "likely.\n",
          "direction": "BACKWARD",
          "scope_phrase": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely"
        }
      ]
    },
    {
      "instance_id": "inst_47",
      "canonical_id": "ent_29",
      "text": "ratio",
      "label": "ENTITY",
      "start_char": 913,
      "end_char": 918,
      "sentence_text": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0456603",
          "score": 0.968,
          "definition": "Quotient of quantities of the same kind for different components within the same system.",
          "aliases": [
            "ratios",
            "Ratios",
            "Ratio (property) (qualifier value)",
            "RATIO",
            "Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5447121",
          "score": 0.738,
          "definition": "The ratio of two concentration values.",
          "aliases": [
            "Ratio Concentration"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264679",
          "score": 0.736,
          "definition": "The quotient of the mass concentration of one substance divided by the mass concentration of another substance within the same system.",
          "aliases": [
            "Mass ratio (property)",
            "MRTO",
            "Mass ratio (property) (qualifier value)",
            "Mass Ratio",
            "*Mass Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264675",
          "score": 0.706,
          "definition": "The ratio of the length of time for one event and the length of time for another event.",
          "aliases": [
            "TRTO",
            "Time Ratio",
            "Time ratio (property) (qualifier value)",
            "Time ratio (property)",
            "TRto"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "likely.\n",
          "direction": "BACKWARD",
          "scope_phrase": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely"
        }
      ]
    },
    {
      "instance_id": "inst_48",
      "canonical_id": "ent_33",
      "text": "intrahepatic",
      "label": "ENTITY",
      "start_char": 938,
      "end_char": 950,
      "sentence_text": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C1512948",
          "score": 0.952,
          "definition": "Within the liver.",
          "aliases": [
            "Intrahepatic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1512952",
          "score": 0.952,
          "definition": "Intrahepatic route of drug administration is a method of drug delivery within the liver, predominantly via hepatic vein or artery. Regimen might be more beneficial then systemic one by delivering a higher dose of drug to the liver and reducing overall systemic exposure.",
          "aliases": [
            "Intrahepatic Route of Administration",
            "Intrahepatic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2959572",
          "score": 0.791,
          "definition": "A route that begins within the liver.",
          "aliases": [
            "Intrahepatic route (qualifier value)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1134564",
          "score": 0.773,
          "definition": "Administration of a fluid form of the drug via a blood vessel into the liver over the sustained period of time.",
          "aliases": [
            "hepatic artery infusion",
            "Intrahepatic Infusion Procedure",
            "intrahepatic infusion procedure",
            "HAI",
            "hepatic arterial infusion"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0005396",
          "score": 0.77,
          "definition": "Tumors or cancer of the BILE DUCTS.",
          "aliases": [
            "Bile Duct Tumor",
            "Neoplasms, Bile Duct",
            "Neoplasm, Bile Duct",
            "Bile Duct Neoplasms",
            "Bile Duct Neoplasm"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "likely.\n",
          "direction": "BACKWARD",
          "scope_phrase": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely"
        }
      ]
    },
    {
      "instance_id": "inst_49",
      "canonical_id": "ent_34",
      "text": "mechanical",
      "label": "ENTITY",
      "start_char": 952,
      "end_char": 962,
      "sentence_text": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0443254",
          "score": 0.964,
          "definition": null,
          "aliases": [
            "mechanical",
            "Mechanical",
            "Mechanical (qualifier value)",
            "mechanical method"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5392102",
          "score": 0.82,
          "definition": "Evaluation of mechanical properties of material or a device.",
          "aliases": [
            "Mechanical Testing",
            "Testing, Mechanical",
            "Tests, Mechanical",
            "Mechanical Test",
            "Test, Mechanical"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0376706",
          "score": 0.793,
          "definition": "The branch of physics which deals with the motions of material bodies, including kinematics, dynamics, and statics. When the laws of mechanics are applied to living structures, as to the locomotor system, it is referred to as BIOMECHANICAL PHENOMENA. (From Dorland, 28th ed)",
          "aliases": [
            "mechanic",
            "Mechanics",
            "mechanics"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0038442",
          "score": 0.78,
          "definition": "A purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area.",
          "aliases": [
            "Mechanical stress",
            "Mechanical Stresses",
            "Mechanical Stress",
            "mechanical stress",
            "Stresses, Mechanical"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0018829",
          "score": 0.778,
          "definition": "A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. (Dorland, 28th ed)",
          "aliases": [
            "Hearts, Artificial",
            "Artificial heart",
            "Prostheses, Heart",
            "Heart, Artificial",
            "Artificial heart, device"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "likely.\n",
          "direction": "BACKWARD",
          "scope_phrase": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely"
        }
      ]
    },
    {
      "instance_id": "inst_50",
      "canonical_id": "ent_35",
      "text": "medical",
      "label": "ENTITY",
      "start_char": 966,
      "end_char": 973,
      "sentence_text": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0199168",
          "score": 0.991,
          "definition": "<p>Provision of diagnostic and/or therapeutic treatment.</p>",
          "aliases": [
            "Medical service (procedure)",
            "medical service",
            "Medical",
            "Medical service",
            "service medical"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0205476",
          "score": 0.991,
          "definition": "Relating to the study or practice of medicine.",
          "aliases": [
            "Medical (qualifier value)",
            "medical",
            "Medical"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1547184",
          "score": 0.991,
          "definition": null,
          "aliases": [
            "Medical"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1561579",
          "score": 0.991,
          "definition": null,
          "aliases": [
            "Medical"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0175718",
          "score": 0.761,
          "definition": "Rods of bone, metal, or other material used for fixation of the fragments or ends of fractured bones.",
          "aliases": [
            "Bone pin, device",
            "Pins",
            "Bone nail",
            "Pin, Bone",
            "Bone Nails"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "likely.\n",
          "direction": "BACKWARD",
          "scope_phrase": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely"
        }
      ]
    },
    {
      "instance_id": "inst_51",
      "canonical_id": "ent_36",
      "text": "cholestasis",
      "label": "ENTITY",
      "start_char": 975,
      "end_char": 986,
      "sentence_text": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0008370",
          "score": 0.992,
          "definition": "Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).",
          "aliases": [
            "obstruction bile duct",
            "Obstruction of bile duct, NOS",
            "Occlusion of bile duct, NOS",
            "bile stasis",
            "Obstruction of bile duct (disorder)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0268318",
          "score": 0.716,
          "definition": "Intrahepatic cholestasis of pregnancy (ICP) is a cholestatic disorder characterized by (i) pruritus with onset in the second or third trimester of pregnancy, (ii) elevated serum aminotransferases and bile acid levels, and (iii) spontaneous relief of signs and symptoms within two to three weeks after delivery.",
          "aliases": [
            "Pregnancy-related cholestasis",
            "Pregnancy related cholestasis",
            "Obstetric Cholestasis",
            "Cholestasis, Pregnancy-Related",
            "ricp"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0008366",
          "score": 0.701,
          "definition": "Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17.",
          "aliases": [
            "cholestane compound",
            "cholestanes",
            "cholestane"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "likely.\n",
          "direction": "BACKWARD",
          "scope_phrase": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely"
        }
      ]
    },
    {
      "instance_id": "inst_52",
      "canonical_id": "ent_37",
      "text": "Drug",
      "label": "ENTITY",
      "start_char": 1003,
      "end_char": 1007,
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0013227",
          "score": 0.995,
          "definition": "Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.",
          "aliases": [
            "Drug/agent",
            "drugs",
            "Preparations, Pharmaceutic",
            "Medicinal product (product)",
            "Medication, NOS"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1254351",
          "score": 0.995,
          "definition": "Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.",
          "aliases": [
            "Pharmacological Substance",
            "Drug",
            "Pharmacologic Substance",
            "Pharmaceuticals",
            "Pharmaceutical Agent"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0687133",
          "score": 0.891,
          "definition": "The action of a drug that may affect the activity, metabolism, or toxicity of another drug.",
          "aliases": [
            "drug drug interaction",
            "Drug interactions",
            "Drug interaction (finding)",
            "drug interaction with",
            "Drug interaction with drug (finding)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3273588",
          "score": 0.85,
          "definition": "A syringe that lacks a conventional plunger, resembles a writing pen, and is designed to dispense a pre-loaded dose of a drug. It may be designed to deliver a single dose or be designed for repeated use.",
          "aliases": [
            "Pre-filled Pen Syringe",
            "Drug Pen",
            "Pen"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0033262",
          "score": 0.809,
          "definition": "A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.",
          "aliases": [
            "Precursors, Drug",
            "drugs pros",
            "Pro-Drug",
            "drugs pro",
            "prodrug"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_53",
      "canonical_id": "ent_38",
      "text": "induced",
      "label": "ENTITY",
      "start_char": 1008,
      "end_char": 1015,
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205263",
          "score": 0.973,
          "definition": "The act of bringing about something.",
          "aliases": [
            "Inducible",
            "Inducing",
            "Induce",
            "Induced",
            "Induction"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3898767",
          "score": 0.735,
          "definition": "A chemical or physical agent that turns on gene expression.",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C5392225",
          "score": 0.722,
          "definition": "Stimulating demand by providing or selling of sometimes unnecessary services to users accompanied by exercising power on behalf of service providers.",
          "aliases": [
            "Demands, Induced",
            "Demand, Induced",
            "Induced Demands"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1512710",
          "score": 0.72,
          "definition": "Any mutation that occurs in response to inducing agents, including radiation, viral infection, and a broad variety of mutagenic chemicals.",
          "aliases": [
            "Induced Sequence Alteration",
            "Induced DNA Alteration"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0259787",
          "score": 0.707,
          "definition": "Artificially induced UTERINE CONTRACTION.",
          "aliases": [
            "Labor Induction",
            "Inductions, Labor",
            "of labour induction",
            "Labour Induction",
            "Induction of labor"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_54",
      "canonical_id": "ent_36",
      "text": "cholestasis",
      "label": "ENTITY",
      "start_char": 1016,
      "end_char": 1027,
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0008370",
          "score": 0.992,
          "definition": "Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).",
          "aliases": [
            "obstruction bile duct",
            "Obstruction of bile duct, NOS",
            "Occlusion of bile duct, NOS",
            "bile stasis",
            "Obstruction of bile duct (disorder)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0268318",
          "score": 0.716,
          "definition": "Intrahepatic cholestasis of pregnancy (ICP) is a cholestatic disorder characterized by (i) pruritus with onset in the second or third trimester of pregnancy, (ii) elevated serum aminotransferases and bile acid levels, and (iii) spontaneous relief of signs and symptoms within two to three weeks after delivery.",
          "aliases": [
            "Pregnancy-related cholestasis",
            "Pregnancy related cholestasis",
            "Obstetric Cholestasis",
            "Cholestasis, Pregnancy-Related",
            "ricp"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0008366",
          "score": 0.701,
          "definition": "Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17.",
          "aliases": [
            "cholestane compound",
            "cholestanes",
            "cholestane"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_55",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 1073,
      "end_char": 1076,
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "CO-OCCURRENCE",
          "trigger_phrase": "presents with a",
          "direction": "FORWARD",
          "scope_phrase": "a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.\nCausative"
        }
      ]
    },
    {
      "instance_id": "inst_56",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 1090,
      "end_char": 1093,
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "CO-OCCURRENCE",
          "trigger_phrase": "presents with a",
          "direction": "FORWARD",
          "scope_phrase": "a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.\nCausative"
        },
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "rather than GGT",
          "direction": "FORWARD",
          "scope_phrase": "GGT, or with an ALT:ALP ratio of<2.\nCausative"
        }
      ]
    },
    {
      "instance_id": "inst_57",
      "canonical_id": "ent_28",
      "text": "ALT",
      "label": "ENTITY",
      "start_char": 1106,
      "end_char": 1109,
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0001899",
          "score": 0.991,
          "definition": "An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.",
          "aliases": [
            "alanine transaminase",
            "transaminase glutamic-pyruvic",
            "Glutamate pyruvate transaminase",
            "ALAT - alanine aminotransferase",
            "Transaminase, Glutamic-Pyruvic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1370889",
          "score": 0.991,
          "definition": "An atypical lipomatous tumor/well differentiated liposarcoma composed of mature adipocytes in which, unlike in benign lipoma, substantial variation in cell size is appreciated alongside nuclear atypia in fat cells or stromal spindle cells. (WHO 2020)",
          "aliases": [
            "Atypical Lipomatous Tumors",
            "Lipomatous Tumor, Atypical",
            "Liposarcoma, well differentiated (morphologic abnormality)",
            "Atypical lipoma",
            "ALT"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2257651",
          "score": 0.991,
          "definition": "Catalysis of the reaction: 2-oxoglutarate + L-alanine = L-glutamate + pyruvate. [EC:2.6.1.2, RHEA:19453]",
          "aliases": [
            "alanine aminotransferase activity",
            "GPT",
            "glutamic acid-pyruvic acid transaminase activity",
            "pyruvate-alanine aminotransferase activity",
            "glutamic-pyruvic aminotransferase activity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4553172",
          "score": 0.991,
          "definition": "The use of a highly concentrated antibiotic solution for the to treatment of catheter-related bloodstream infections.",
          "aliases": [
            "Antibiotic Lock Therapy",
            "ALT"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724507",
          "score": 0.991,
          "definition": "A Turkic language, spoken officially in the Altai Republic of Russia.",
          "aliases": [
            "Gorno-Altay",
            "Southern Altai Language",
            "Gorno-Altai",
            "ALT",
            "Southern Altai"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "CO-OCCURRENCE",
          "trigger_phrase": "presents with a",
          "direction": "FORWARD",
          "scope_phrase": "a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.\nCausative"
        },
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "rather than GGT",
          "direction": "FORWARD",
          "scope_phrase": "GGT, or with an ALT:ALP ratio of<2.\nCausative"
        }
      ]
    },
    {
      "instance_id": "inst_58",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 1110,
      "end_char": 1113,
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "CO-OCCURRENCE",
          "trigger_phrase": "presents with a",
          "direction": "FORWARD",
          "scope_phrase": "a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.\nCausative"
        },
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "rather than GGT",
          "direction": "FORWARD",
          "scope_phrase": "GGT, or with an ALT:ALP ratio of<2.\nCausative"
        }
      ]
    },
    {
      "instance_id": "inst_59",
      "canonical_id": "ent_29",
      "text": "ratio",
      "label": "ENTITY",
      "start_char": 1114,
      "end_char": 1119,
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0456603",
          "score": 0.968,
          "definition": "Quotient of quantities of the same kind for different components within the same system.",
          "aliases": [
            "ratios",
            "Ratios",
            "Ratio (property) (qualifier value)",
            "RATIO",
            "Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5447121",
          "score": 0.738,
          "definition": "The ratio of two concentration values.",
          "aliases": [
            "Ratio Concentration"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264679",
          "score": 0.736,
          "definition": "The quotient of the mass concentration of one substance divided by the mass concentration of another substance within the same system.",
          "aliases": [
            "Mass ratio (property)",
            "MRTO",
            "Mass ratio (property) (qualifier value)",
            "Mass Ratio",
            "*Mass Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264675",
          "score": 0.706,
          "definition": "The ratio of the length of time for one event and the length of time for another event.",
          "aliases": [
            "TRTO",
            "Time Ratio",
            "Time ratio (property) (qualifier value)",
            "Time ratio (property)",
            "TRto"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "CO-OCCURRENCE",
          "trigger_phrase": "presents with a",
          "direction": "FORWARD",
          "scope_phrase": "a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.\nCausative"
        },
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "rather than GGT",
          "direction": "FORWARD",
          "scope_phrase": "GGT, or with an ALT:ALP ratio of<2.\nCausative"
        }
      ]
    },
    {
      "instance_id": "inst_60",
      "canonical_id": "ent_39",
      "text": "Causative drugs",
      "label": "ENTITY",
      "start_char": 1126,
      "end_char": 1141,
      "sentence_text": "Causative drugs would include: antibiotics, immunosuppressants, tricyclic antidepressants and angiotensin converting enzyme inhibitors.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_61",
      "canonical_id": "ent_40",
      "text": "antibiotics",
      "label": "ENTITY",
      "start_char": 1157,
      "end_char": 1168,
      "sentence_text": "Causative drugs would include: antibiotics, immunosuppressants, tricyclic antidepressants and angiotensin converting enzyme inhibitors.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0003232",
          "score": 0.969,
          "definition": "Substances naturally produced by microorganisms or their derivatives that selectively target microorganisms not humans. Antibiotics kill or inhibit the growth of microorganisms by targeting components of the microbial cell absent from human cells, including bacterial cell walls, cell membrane, and 30S or 50S ribosomal subunits. These substances are used in the treatment of bacterial and other microbial infections.",
          "aliases": [
            "Antibiotic (product)",
            "antibiotic products",
            "antibiotics",
            "Antibiotic Drugs",
            "MISCELLANEOUS ANTIBIOTICS"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0003237",
          "score": 0.969,
          "definition": "Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.",
          "aliases": [
            "Antibiotics",
            "Antitubercular Antibiotics",
            "Antibiotics, Antitubercular",
            "antitubercular antibiotics"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3540704",
          "score": 0.969,
          "definition": null,
          "aliases": [
            "Antibiotics for systemic use",
            "Antibiotics"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3540705",
          "score": 0.969,
          "definition": null,
          "aliases": [
            "Antifungal Antibiotics, Topical",
            "Antibiotics"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3540706",
          "score": 0.969,
          "definition": null,
          "aliases": [
            "Antibiotic throat preparations",
            "Antibiotics"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_62",
      "canonical_id": "ent_41",
      "text": "immunosuppressants",
      "label": "ENTITY",
      "start_char": 1170,
      "end_char": 1188,
      "sentence_text": "Causative drugs would include: antibiotics, immunosuppressants, tricyclic antidepressants and angiotensin converting enzyme inhibitors.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0021081",
          "score": 0.992,
          "definition": "Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.",
          "aliases": [
            "Immunosuppressant agent, NOS",
            "Agents, Immunosuppressive",
            "immunosuppressive",
            "immunosuppressant",
            "IMMUNOSUPPRESSANTS"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0021079",
          "score": 0.782,
          "definition": "Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.",
          "aliases": [
            "Anti Rejection Therapy",
            "Immunosuppression",
            "IMMUNE SUPPRESSION",
            "immunosuppression",
            "Therapy, Antirejection"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0021080",
          "score": 0.782,
          "definition": "An Immunosuppressive Effect involves interference with, or restraint of, the function of biologic molecules and complexes, or cellular, cell, or tissue components of a normal immune response.",
          "aliases": [
            "Immunosuppression",
            "Immunosuppressive Effect",
            "immunosuppression",
            "Immunosuppression (Physiology)",
            "Immunosuppression (finding)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0085393",
          "score": 0.769,
          "definition": "A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.",
          "aliases": [
            "Host, Immunosuppressed",
            "Immunosuppressed Hosts",
            "immunosuppressed patient",
            "Patients, Immunocompromised",
            "Hosts, Immunosuppressed"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_63",
      "canonical_id": "ent_42",
      "text": "tricyclic",
      "label": "ENTITY",
      "start_char": 1190,
      "end_char": 1199,
      "sentence_text": "Causative drugs would include: antibiotics, immunosuppressants, tricyclic antidepressants and angiotensin converting enzyme inhibitors.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0003290",
          "score": 0.779,
          "definition": "Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.",
          "aliases": [
            "Tricyclic Antidepressants",
            "Antidepressant Drugs, Tricyclic",
            "Antidepressive Agents, Tricyclic",
            "tricyclic antidepressants",
            "Drugs, Tricyclic Antidepressant"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_64",
      "canonical_id": "ent_43",
      "text": "antidepressants",
      "label": "ENTITY",
      "start_char": 1200,
      "end_char": 1215,
      "sentence_text": "Causative drugs would include: antibiotics, immunosuppressants, tricyclic antidepressants and angiotensin converting enzyme inhibitors.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0003289",
          "score": 0.977,
          "definition": "Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.",
          "aliases": [
            "antidepressive agent",
            "Antidepressive Agent [TC]",
            "Antidepressant",
            "Antidepressant Drugs",
            "ANTIDEPRESSANTS"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0242905",
          "score": 0.794,
          "definition": "A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.",
          "aliases": [
            "Antidepressive Agents, Second Generation",
            "Antidepressive Drugs, Second-Generation",
            "Agents, Second-Generation Antidepressive",
            "Second Generation Antidepressive Agents",
            "Second-Generation Antidepressive Agents"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0003290",
          "score": 0.775,
          "definition": "Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.",
          "aliases": [
            "Tricyclic Antidepressants",
            "Antidepressant Drugs, Tricyclic",
            "Antidepressive Agents, Tricyclic",
            "tricyclic antidepressants",
            "Drugs, Tricyclic Antidepressant"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_65",
      "canonical_id": "ent_44",
      "text": "angiotensin converting enzyme inhibitors",
      "label": "ENTITY",
      "start_char": 1220,
      "end_char": 1260,
      "sentence_text": "Causative drugs would include: antibiotics, immunosuppressants, tricyclic antidepressants and angiotensin converting enzyme inhibitors.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0003015",
          "score": 0.977,
          "definition": "A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.",
          "aliases": [
            "Angiotensin-Converting Enzyme Inhibitor",
            "Angiotensin-converting enzyme inhibitor agent, NOS",
            "angiotensin converting enzyme inhibitor",
            "ace inhibitors",
            "ace inhibitor"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0919881",
          "score": 0.834,
          "definition": "Fetal embryopathy associated with maternal angiotensis converting enzyme (ACE) inhibitor use during pregnancy that may include fetal acute renal failure, growth restriction, oligohydramnios, calvaria abnormalities, preterm birth, and pulmonary hypoplasia with respiratory distress.",
          "aliases": [
            "ACE Inhibitor Fetopathy"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0022709",
          "score": 0.833,
          "definition": "A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-&#x7C;-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020).",
          "aliases": [
            "angiotensin i converting enzyme",
            "Angiotensin converting enzyme",
            "Dipeptidyl carboxypeptidase I",
            "angiotensin converting enzymes",
            "Angiotensin Converting Enzyme"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_66",
      "canonical_id": "ent_45",
      "text": "Primary Biliary Cirrhosis",
      "label": "ENTITY",
      "start_char": 1265,
      "end_char": 1290,
      "sentence_text": "In Primary Biliary Cirrhosis, an autoimmune condition of the intrahepatic biliary ducts, the level of ALP is generally greater than that of GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0008312",
          "score": 0.98,
          "definition": "An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.",
          "aliases": [
            "PRIMARY BILIARY CIRRHOSIS",
            "Primary biliary cholangitis (disorder)",
            "primary biliary cirrhosis",
            "Primary Biliary Cirrhosis",
            "Chronic non-suppurative destructive cholangitis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0023892",
          "score": 0.832,
          "definition": "FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.",
          "aliases": [
            "cirrhosis biliary",
            "BILIARY CIRRHOSIS",
            "Biliary cirrhosis",
            "Cirrhosis, Biliary",
            "Liver Cirrhoses, Biliary"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0748397",
          "score": 0.759,
          "definition": "An autoimmune disorder characterised by the association of primary biliary cirrhosis with limited cutaneous systemic sclerosis. Onset occurs between 30-65 years. Occurs sporadically, but rare familial cases with an unknown inheritance pattern have been observed. There is no cure and management is mainly supportive.",
          "aliases": [
            "Primary biliary cirrhosis co-occurrent with systemic scleroderma (disorder)",
            "PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA",
            "REYNOLDS SYNDROME",
            "Reynolds syndrome",
            "Primary biliary cirrhosis and systemic scleroderma"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0238065",
          "score": 0.757,
          "definition": "Biliary cirrhosis due to obstruction of the extrahepatic ducts.",
          "aliases": [
            "Secondary Biliary Cirrhosis",
            "Liver Cirrhosis, Obstructive",
            "CIRRHOSIS, SECONDARY BILIARY",
            "BILIARY CIRRHOSIS SECONDARY",
            "Obstructive Liver Cirrhosis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_67",
      "canonical_id": "ent_46",
      "text": "autoimmune condition",
      "label": "ENTITY",
      "start_char": 1295,
      "end_char": 1315,
      "sentence_text": "In Primary Biliary Cirrhosis, an autoimmune condition of the intrahepatic biliary ducts, the level of ALP is generally greater than that of GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0004364",
          "score": 0.961,
          "definition": "Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.",
          "aliases": [
            "AUTOIMMUNE DISORDER NOS",
            "autoimmunities",
            "Autoimmune Disease",
            "Autoimmune Disorder",
            "autoimmunity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4551524",
          "score": 0.71,
          "definition": "Pertaining to autoimmunity.",
          "aliases": [
            "Autoimmune",
            "autoimmune"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0443146",
          "score": 0.702,
          "definition": "A specific humoral or cell-mediated immune response against autologous (self) antigens.",
          "aliases": [
            "autoimmune reactions",
            "autoimmune response",
            "autoimmune reaction",
            "Autoimmune Reaction",
            "Autoimmune Response"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_68",
      "canonical_id": "ent_33",
      "text": "intrahepatic",
      "label": "ENTITY",
      "start_char": 1323,
      "end_char": 1335,
      "sentence_text": "In Primary Biliary Cirrhosis, an autoimmune condition of the intrahepatic biliary ducts, the level of ALP is generally greater than that of GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C1512948",
          "score": 0.952,
          "definition": "Within the liver.",
          "aliases": [
            "Intrahepatic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1512952",
          "score": 0.952,
          "definition": "Intrahepatic route of drug administration is a method of drug delivery within the liver, predominantly via hepatic vein or artery. Regimen might be more beneficial then systemic one by delivering a higher dose of drug to the liver and reducing overall systemic exposure.",
          "aliases": [
            "Intrahepatic Route of Administration",
            "Intrahepatic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2959572",
          "score": 0.791,
          "definition": "A route that begins within the liver.",
          "aliases": [
            "Intrahepatic route (qualifier value)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1134564",
          "score": 0.773,
          "definition": "Administration of a fluid form of the drug via a blood vessel into the liver over the sustained period of time.",
          "aliases": [
            "hepatic artery infusion",
            "Intrahepatic Infusion Procedure",
            "intrahepatic infusion procedure",
            "HAI",
            "hepatic arterial infusion"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0005396",
          "score": 0.77,
          "definition": "Tumors or cancer of the BILE DUCTS.",
          "aliases": [
            "Bile Duct Tumor",
            "Neoplasms, Bile Duct",
            "Neoplasm, Bile Duct",
            "Bile Duct Neoplasms",
            "Bile Duct Neoplasm"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_69",
      "canonical_id": "ent_47",
      "text": "biliary ducts",
      "label": "ENTITY",
      "start_char": 1336,
      "end_char": 1349,
      "sentence_text": "In Primary Biliary Cirrhosis, an autoimmune condition of the intrahepatic biliary ducts, the level of ALP is generally greater than that of GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0005400",
          "score": 0.984,
          "definition": "The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.",
          "aliases": [
            "Inflammation of common bile duct",
            "Bile duct structure (body structure)",
            "Bile ducts",
            "bile duct",
            "bile ductule"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4071904",
          "score": 0.984,
          "definition": null,
          "aliases": [
            "Abdomen>Biliary ducts",
            "Biliary ducts"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4053717",
          "score": 0.756,
          "definition": "A hollow tube that is advanced into an obstructed bile duct to allow the flow of bile into the bowel.",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C0521378",
          "score": 0.755,
          "definition": "A term that refers to the biliary tract structures.",
          "aliases": [
            "biliary",
            "Biliary"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0009437",
          "score": 0.744,
          "definition": "The largest bile duct. It is formed by the junction of the CYSTIC DUCT and the COMMON HEPATIC DUCT.",
          "aliases": [
            "Common Duct",
            "Common Bile Duct",
            "Common bile duct",
            "choledochus",
            "Common bile duct structure"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_70",
      "canonical_id": "ent_48",
      "text": "level",
      "label": "ENTITY",
      "start_char": 1355,
      "end_char": 1360,
      "sentence_text": "In Primary Biliary Cirrhosis, an autoimmune condition of the intrahepatic biliary ducts, the level of ALP is generally greater than that of GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0441889",
          "score": 0.988,
          "definition": "A position on a scale measuring intensity, quality, or amount.",
          "aliases": [
            "Level",
            "Levels",
            "levels",
            "Degree",
            "Levels (qualifier value)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0456079",
          "score": 0.988,
          "definition": null,
          "aliases": [
            "Level (attribute)",
            "Level"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1547707",
          "score": 0.988,
          "definition": "A location comprising a single level of a multilevel building.",
          "aliases": [
            "Floor",
            "Story",
            "Level"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5551416",
          "score": 0.92,
          "definition": "Work - sedentary (secretarial, etc.)",
          "aliases": [
            "Level 1"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5551417",
          "score": 0.92,
          "definition": "Identification is fully validated by confirming the structure and metabolite assignment using a reference standard.",
          "aliases": [
            "Level 1 Metabolite Identification Confidence",
            "Level 1",
            "Validation Identification",
            "Metabolite Identification Confidence Level 1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_71",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 1364,
      "end_char": 1367,
      "sentence_text": "In Primary Biliary Cirrhosis, an autoimmune condition of the intrahepatic biliary ducts, the level of ALP is generally greater than that of GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_72",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 1402,
      "end_char": 1405,
      "sentence_text": "In Primary Biliary Cirrhosis, an autoimmune condition of the intrahepatic biliary ducts, the level of ALP is generally greater than that of GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_73",
      "canonical_id": "ent_49",
      "text": "transaminases",
      "label": "ENTITY",
      "start_char": 1421,
      "end_char": 1434,
      "sentence_text": "In this case, transaminases are invariably normal or only minimally elevated.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002594",
          "score": 0.969,
          "definition": "A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.",
          "aliases": [
            "aminotransferase",
            "Aminotransferases",
            "Transaminases",
            "transaminases",
            "Substance with aminotransferase mechanism of action (substance)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0919834",
          "score": 0.969,
          "definition": null,
          "aliases": [
            "transaminases"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0002484",
          "score": 0.838,
          "definition": "Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4.",
          "aliases": [
            "amidinotransferase",
            "Transamidinases",
            "Amidinotransferase",
            "Transamidinase",
            "Amidinotransferases"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0004002",
          "score": 0.834,
          "definition": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.",
          "aliases": [
            "s-asat",
            "Glutamic oxaloacetic transaminase (GOT)",
            "Aspartate Aminotransferases",
            "glutamic oxaloacetic transaminase",
            "Glutamic Oxaloacetic Transaminase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4507520",
          "score": 0.834,
          "definition": "Aspartate aminotransferase, cytoplasmic (413 aa, ~46 kDa) is encoded by the human GOT1 gene. This protein is involved in amino acid metabolism.",
          "aliases": [
            "GOT1 protein, human",
            "Soluble Glutamic-Oxaloacetic Transaminase 1",
            "Transaminase A",
            "Glutamate Oxaloacetate Transaminase-1",
            "Aspartate Aminotransferase, Cytoplasmic"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_74",
      "canonical_id": "ent_17",
      "text": "normal",
      "label": "ENTITY",
      "start_char": 1450,
      "end_char": 1456,
      "sentence_text": "In this case, transaminases are invariably normal or only minimally elevated.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205307",
          "score": 0.98,
          "definition": "In pathology, a term that is used to describe a tissue specimen that has a normal appearance.",
          "aliases": [
            "Normal (qualifier value)",
            "unremarkable",
            "normal",
            "Unremarkable",
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1550457",
          "score": 0.98,
          "definition": "<p>The result or observation value is within the reference range or expected norm (as defined for the respective test procedure).</p><p>\\[Note: Applies to numeric or non-numeric results.\\]</p>",
          "aliases": [
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1550469",
          "score": 0.98,
          "definition": "<p>Privacy metadata indicating the level of protection required to safeguard personal and healthcare information, which if disclosed without authorization, would present a considerable risk of harm to an individual's reputation and sense of privacy.</p><i>Usage Note:</i>The level of protection afforded normatively confidential information is dictated by the prevailing normative privacy policies, which are intended to engender patient trust in their healthcare providers.<p>Privacy policies mandating normative levels of protection, which preempt less protective privacy policies when the information is used in the delivery and management of healthcare. May be pre-empted by jurisdictional law (e.g., for public health reporting or emergency treatment).</p><p>Confidentiality code total order hierarchy: Normal (N) is less protective than *V* and *R*, and subsumes all other protection levels (i.e., *M, L, and U*).</p><p>**Map:**Partial Map to ISO 13606-4 Sensitivity Level (3) Clinical Care when purpose of use is treatment: Default for normal clinical care access (i.e., most clinical staff directly caring for the patient should be able to access nearly all of the EHR). Maps to normal confidentiality for treatment information but not to ancillary care, payment and operations.</p><b>Examples:</b><p>n the US, this includes what HIPAA identifies as protected health information (PHI) under 45 CFR Section 160.103.</p>",
          "aliases": [
            "normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1551394",
          "score": 0.98,
          "definition": "<p>No Corrective Action Needed</p>",
          "aliases": [
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1553386",
          "score": 0.98,
          "definition": "<p>Encompasses the expected states of an Act, but excludes \"nullified\" and \"obsolete\" which represent unusual terminal states for the life-cycle.</p>",
          "aliases": [
            "normal"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_75",
      "canonical_id": "ent_10",
      "text": "elevated",
      "label": "ENTITY",
      "start_char": 1475,
      "end_char": 1483,
      "sentence_text": "In this case, transaminases are invariably normal or only minimally elevated.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205250",
          "score": 0.978,
          "definition": "An elevated level or position or degree; greater than normal in degree or intensity or amount.",
          "aliases": [
            "High",
            "elevate",
            "Highly",
            "high",
            "elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3163633",
          "score": 0.978,
          "definition": "Raised or increased above normal levels or limits.",
          "aliases": [
            "Elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0520886",
          "score": 0.907,
          "definition": "An electrocardiographic finding of ST segment elevation above the baseline.",
          "aliases": [
            "ST SEGMENT ELEVATED",
            "st elevated",
            "elevation st",
            "st segment elevation",
            "st elevation ekg"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151904",
          "score": 0.863,
          "definition": "An increase in the level of aspartate aminotransferase in the blood.",
          "aliases": [
            "SGOT, ELEVATED",
            "ast elevated",
            "GLUTAMIC-OXALOACETIC TRANSAM INCR",
            "Elevated serum AST",
            "AST INCREASED"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0221106",
          "score": 0.856,
          "definition": "An abnormally high blood pH (usually defined as 7.41 or above). [PMID:24381489]",
          "aliases": [
            "increase ph",
            "Acid deficit",
            "Baseosis",
            "increasing ph",
            "ELEVATED PH"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_76",
      "canonical_id": "ent_50",
      "text": "criteria",
      "label": "ENTITY",
      "start_char": 1508,
      "end_char": 1516,
      "sentence_text": "If either of these two criteria is absent, imaging and liver biopsy become necessary.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0243161",
          "score": 0.977,
          "definition": "That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.",
          "aliases": [
            "Criteria",
            "Criterion",
            "criterion"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3897119",
          "score": 0.794,
          "definition": "An update to the MacDonald criteria for assessing disease progression and treatment response in glioblastoma multiforme (GBM).",
          "aliases": [
            "RANO",
            "RANO Response Criteria",
            "Response Assessment Criteria for Glioblastoma",
            "RANO Criteria"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4744412",
          "score": 0.79,
          "definition": "A validated risk prediction tool for patients with metastatic renal cell carcinoma (mRCC) receiving first-line targeted therapy. The model considers: Karnofsky performance status less than 80%, time from diagnosis to first-line targeted therapy less than 1 year, hemoglobin concentration less than lower limit of normal, neutrophil count greater than upper limit of normal, platelet count greater than upper limit of normal, and serum calcium concentration greater than upper limit of normal.",
          "aliases": [
            "Heng Criteria",
            "IMDC Criteria",
            "IMDC Risk",
            "IMDC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3897634",
          "score": 0.744,
          "definition": "A standard from which a judgment concerning an event severity can be established.",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C4330479",
          "score": 0.726,
          "definition": "Response assessment criteria for the evaluation of patients undergoing immunotherapy for the treatment of malignant glioma. These recommendations integrate guidance for the determination and confirmation of tumor progression based on the response assessment in neuro-oncology (RANO) working group and the immune-related response criteria (irRC).",
          "aliases": [
            "iRANO",
            "iRANO Criteria"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "HYPOTHETICAL",
          "trigger_phrase": "If either",
          "direction": "FORWARD",
          "scope_phrase": "either of these two criteria is absent, imaging and liver biopsy become necessary.\nAST"
        }
      ]
    },
    {
      "instance_id": "inst_77",
      "canonical_id": "ent_51",
      "text": "absent",
      "label": "ENTITY",
      "start_char": 1520,
      "end_char": 1526,
      "sentence_text": "If either of these two criteria is absent, imaging and liver biopsy become necessary.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0332197",
          "score": 0.969,
          "definition": "Not existing in a specified place at a specified time.",
          "aliases": [
            "absent",
            "absence",
            "Absent",
            "Absence of",
            "Not Present"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5237010",
          "score": 0.969,
          "definition": "An indication that expression of a gene, RNA species or protein is not detected in a sample.",
          "aliases": [
            "Negative",
            "Loss of Expression",
            "Not Expressed",
            "Absent",
            "Expression Negative"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1709643",
          "score": 0.865,
          "definition": "Indicates relative presence or absence. From the enumeration AbsoluteCallTypeEnum (Present / Absent / Marginal / No call) or ComparisonCallTypeEnum (Increase / Marginal Increase / Decrease / Marginal Decrease / No change / No Call / Unknown), as specified by the dataType. (caMAGE)",
          "aliases": [
            "Present/Absent",
            "Present Absent"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0265740",
          "score": 0.79,
          "definition": "Complete absence of all nasal structures. [HPO:probinson]",
          "aliases": [
            "Agenesis of nose",
            "Congenital absence of the nose",
            "Aplasia of the nose",
            "Arhinia",
            "Underdevelopment of nose"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0265594",
          "score": 0.79,
          "definition": "The total absence of the hand, with no bony elements distal to the radius or ulna. [PMID:19125433]",
          "aliases": [
            "Congenital absence of hand (disorder)",
            "Absent hand",
            "Agenesis of forepaw",
            "Congenital absence of hand",
            "Acheiria"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "HYPOTHETICAL",
          "trigger_phrase": "If either",
          "direction": "FORWARD",
          "scope_phrase": "either of these two criteria is absent, imaging and liver biopsy become necessary.\nAST"
        }
      ]
    },
    {
      "instance_id": "inst_78",
      "canonical_id": "ent_52",
      "text": "imaging",
      "label": "ENTITY",
      "start_char": 1528,
      "end_char": 1535,
      "sentence_text": "If either of these two criteria is absent, imaging and liver biopsy become necessary.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0011923",
          "score": 0.984,
          "definition": "Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.",
          "aliases": [
            "Diagnostic imaging",
            "Diagnostic imaging, NOS",
            "Imaging, Diagnostic",
            "Clinical imaging",
            "Diagnostic imaging, not elsewhere classified"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0079595",
          "score": 0.984,
          "definition": "Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.",
          "aliases": [
            "Medical Imaging",
            "Diagnostic Imaging Technique",
            "Imaging (Procedure)",
            "imaging technique",
            "medical imaging"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1704382",
          "score": 0.984,
          "definition": "Any of a number of technologies that permits the visualization and acquisition of images into a physical or electronic record.",
          "aliases": [
            "Imaging Technologies",
            "Imaging",
            "Imaging Technology"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1287399",
          "score": 0.838,
          "definition": "The result of an evaluation technique using a visual display of structural or functional patterns of organs or tissues that is performed to determine the presence, absence, or degree of a condition.",
          "aliases": [
            "Imaging finding",
            "Imaging Finding",
            "Imaging Result",
            "Imaging finding (finding)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0203668",
          "score": 0.835,
          "definition": "A nuclear imaging method used to evaluate pathological bone metabolism.",
          "aliases": [
            "Bone imaging",
            "Bone imaging, NOS",
            "bone scanning",
            "bone scan",
            "Radioisotope scan of bone"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "HYPOTHETICAL",
          "trigger_phrase": "If either",
          "direction": "FORWARD",
          "scope_phrase": "either of these two criteria is absent, imaging and liver biopsy become necessary.\nAST"
        }
      ]
    },
    {
      "instance_id": "inst_79",
      "canonical_id": "ent_53",
      "text": "liver biopsy",
      "label": "ENTITY",
      "start_char": 1540,
      "end_char": 1552,
      "sentence_text": "If either of these two criteria is absent, imaging and liver biopsy become necessary.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0193388",
          "score": 0.973,
          "definition": "Removal of tissue from the liver for microscopic examination.",
          "aliases": [
            "liver biopsy procedure",
            "Biopsy of liver",
            "Liver biopsy",
            "Biopsy of liver, NOS",
            "Liver Biopsy"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1548877",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "Liver Biopsy"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0879184",
          "score": 0.745,
          "definition": "Vascular catheters designed for the removal of tissue from the liver through the vascular system. These catheters typically consist of a 9 Fr plastic tube with a biopsy needle that is advanced through its lumen; the needle frequently includes a hollow stylet within it to prevent aspiration of the sample into the syringe. They are usually introduced through the jugular vein, advanced to the inferior vena cava, and to the hepatic veins; the needle is plunged into the liver and removed in one continuous motion while suction is maintained with a syringe. Contrast medium should be injected after each biopsy attempt to check for liver capsule perforation. Liver biopsy catheters through the vascular system are used as an alternative to percutaneous biopsy in patients with abnormal blood clotting or massive ascites.",
          "aliases": [
            "Liver Biopsy Catheters"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0558534",
          "score": 0.744,
          "definition": "The extraction of a sample of liver tissue taken via the insertion of a needle through the skin and into the liver.",
          "aliases": [
            "Percutaneous liver biopsy (procedure)",
            "Percutaneous Liver Biopsy"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0581276",
          "score": 0.732,
          "definition": "Removal of tissue from the liver for microscopic examination, using a needle.",
          "aliases": [
            "Needle Biopsy of Liver",
            "Needle biopsy of liver (procedure)",
            "liver biopsy needle",
            "Needle biopsy of liver",
            "liver needle biopsy"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "HYPOTHETICAL",
          "trigger_phrase": "If either",
          "direction": "FORWARD",
          "scope_phrase": "either of these two criteria is absent, imaging and liver biopsy become necessary.\nAST"
        }
      ]
    },
    {
      "instance_id": "inst_80",
      "canonical_id": "ent_22",
      "text": "AST",
      "label": "ENTITY",
      "start_char": 1571,
      "end_char": 1574,
      "sentence_text": "AST and ALP are used within some scoring criteria to monitor the effects of ursodeoxycholic acid in the management of PBC.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0004002",
          "score": 0.998,
          "definition": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.",
          "aliases": [
            "s-asat",
            "Glutamic oxaloacetic transaminase (GOT)",
            "Aspartate Aminotransferases",
            "glutamic oxaloacetic transaminase",
            "Glutamic Oxaloacetic Transaminase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415181",
          "score": 0.998,
          "definition": "This gene plays a role in amino acid metabolism, the tricarboxylic acid cycle and the urea cycle.",
          "aliases": [
            "glutamate oxaloacetate transaminase 1",
            "glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)",
            "GOT1 Gene",
            "GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE",
            "glutamic-oxaloacetic transaminase 1"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1420113",
          "score": 0.998,
          "definition": null,
          "aliases": [
            "sialic acid storage disease",
            "SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5",
            "NSD",
            "solute carrier family 17 member 5",
            "SIASD"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724380",
          "score": 0.998,
          "definition": "A West Iberian Romance language spoken in the Principality of Asturias, Spain.",
          "aliases": [
            "AST",
            "Asturian Language",
            "Bable",
            "Asturian"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_81",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 1579,
      "end_char": 1582,
      "sentence_text": "AST and ALP are used within some scoring criteria to monitor the effects of ursodeoxycholic acid in the management of PBC.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_82",
      "canonical_id": "ent_54",
      "text": "scoring criteria",
      "label": "ENTITY",
      "start_char": 1604,
      "end_char": 1620,
      "sentence_text": "AST and ALP are used within some scoring criteria to monitor the effects of ursodeoxycholic acid in the management of PBC.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0243161",
          "score": 0.714,
          "definition": "That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.",
          "aliases": [
            "Criteria",
            "Criterion",
            "criterion"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_83",
      "canonical_id": "ent_55",
      "text": "effects of",
      "label": "ENTITY",
      "start_char": 1636,
      "end_char": 1646,
      "sentence_text": "AST and ALP are used within some scoring criteria to monitor the effects of ursodeoxycholic acid in the management of PBC.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C1280500",
          "score": 0.869,
          "definition": "A phenomenon that follows and is caused by some previous phenomenon.",
          "aliases": [
            "effects",
            "Effect",
            "Effect (qualifier value)",
            "effect"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0543419",
          "score": 0.78,
          "definition": "A pathologic condition that results from a disease, treatment, or injury.",
          "aliases": [
            "aftereffects",
            "late effects",
            "Sequela",
            "effects late",
            "Sequelae"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0034526",
          "score": 0.755,
          "definition": "Used for effects of ionizing and nonionizing radiation upon living organisms, organs and tissues, and their constituents, and upon physiologic processes. It includes the effect of irradiation on drugs and chemicals.",
          "aliases": [
            "radiation effects"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001688",
          "score": 0.752,
          "definition": "Used with drugs, chemicals, or biological agents in accepted dosage - or with physical agents or manufactured products in normal usage - when intended for diagnostic, therapeutic, prophylactic, or anesthetic purposes. It is used also for adverse effects or complications of diagnostic, therapeutic, prophylactic, anesthetic, surgical, or other procedures.",
          "aliases": [
            "adverse effects",
            "side effects"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0879626",
          "score": 0.752,
          "definition": "The term was used in various ways in the past, to describe unintended effects of medical intervention, usually negative (unfavourable), but also positive (favourable) ones. It is recommended that this term no longer be used and particularly should not be regarded as synonymous with adverse event or adverse reaction.",
          "aliases": [
            "adverse effect",
            "therapy adverse effect",
            "treatment side effects",
            "treatment adverse effects",
            "Treatment Side Effects"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_84",
      "canonical_id": "ent_56",
      "text": "ursodeoxycholic acid",
      "label": "ENTITY",
      "start_char": 1647,
      "end_char": 1667,
      "sentence_text": "AST and ALP are used within some scoring criteria to monitor the effects of ursodeoxycholic acid in the management of PBC.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0042105",
          "score": 0.982,
          "definition": "An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.",
          "aliases": [
            "Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7beta)-",
            "Deoxyursocholic Acid",
            "(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-oic acid",
            "Acido ursodeossicolico",
            "Product containing ursodeoxycholic acid (medicinal product)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0011479",
          "score": 0.825,
          "definition": "A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.",
          "aliases": [
            "Cholan-24-oic acid, 3,12-dihydroxy-, (3alpha,5beta,12alpha)-",
            "7\u03b1-deoxycholic acid",
            "Deoxycholic acid (substance)",
            "DEOXYCHOLIC ACID",
            "Product containing deoxycholic acid (medicinal product)"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_85",
      "canonical_id": "ent_57",
      "text": "management",
      "label": "ENTITY",
      "start_char": 1675,
      "end_char": 1685,
      "sentence_text": "AST and ALP are used within some scoring criteria to monitor the effects of ursodeoxycholic acid in the management of PBC.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0001554",
          "score": 0.977,
          "definition": "Performing or possessing executive duties; acting as a supervisor or manager.",
          "aliases": [
            "administration [executive duty]",
            "Administration, Management",
            "Administration (navigational concept)",
            "Management",
            "Administration"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0376636",
          "score": 0.977,
          "definition": "A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)",
          "aliases": [
            "Management, Disease",
            "management",
            "Disease management",
            "disease management",
            "Disease Managements"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1273870",
          "score": 0.977,
          "definition": "The act of conducting, controlling or supervising something.",
          "aliases": [
            "Supervision",
            "Management procedure",
            "Managing",
            "Oversight",
            "management procedures"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3273539",
          "score": 0.977,
          "definition": "A class of professional or vocational positions of employment that involve management.",
          "aliases": [
            "Management",
            "Management Occupations"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2735310",
          "score": 0.842,
          "definition": "<p>To perform analytics, evaluation and other secondary uses of treatment and healthcare related information to manage the quality, efficacy, patient safety, population health, and cost effectiveness of healthcare delivery. Explicitly excludes the use of information to organize the delivery of health care for care coordination and case management, or to provide healthcare treatment.</p><i>Usage Note:</i>The concept of care management is narrower than the list of activities related to more general organizational objectives such as provider profiling, education of healthcare and non-healthcare professionals; insurance underwriting, premium rating, reinsurance; organizational legal, medical review, auditing, compliance and fraud and abuse detection; business planning, development, and restructuring; fund-raising; and customer service.<i>Map:</i>Maps to ISO 14265 Classification Term \"Health service management and quality assurance\" described as \"To inform persons or processes responsible for determining the availability, quality, safety, equity and cost-effectiveness of health care services.\"<p>There is a semantic gap in concepts. This classification term is described as activities, i.e., \"to inform persons\" or \"to inform processes\" rather than the rationale for performing actions/operations on information related to the activity.</p>",
          "aliases": [
            "Care management",
            "care management"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_86",
      "canonical_id": "ent_58",
      "text": "PBC",
      "label": "ENTITY",
      "start_char": 1689,
      "end_char": 1692,
      "sentence_text": "AST and ALP are used within some scoring criteria to monitor the effects of ursodeoxycholic acid in the management of PBC.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0008312",
          "score": 0.994,
          "definition": "An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.",
          "aliases": [
            "PRIMARY BILIARY CIRRHOSIS",
            "Primary biliary cholangitis (disorder)",
            "primary biliary cirrhosis",
            "Primary Biliary Cirrhosis",
            "Chronic non-suppurative destructive cholangitis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_87",
      "canonical_id": "ent_3",
      "text": "raised",
      "label": "ENTITY",
      "start_char": 1726,
      "end_char": 1732,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0442818",
          "score": 0.968,
          "definition": null,
          "aliases": [
            "Raised (qualifier value)",
            "Raised",
            "raised"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0178415",
          "score": 0.772,
          "definition": "The amount of prostate specific antigen is increased, based on pre-defined thresholds.",
          "aliases": [
            "Raised prostate specific antigen (finding)",
            "Elevated prostate specific antigen",
            "increased psa",
            "increasing psa",
            "PSA Elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0239984",
          "score": 0.772,
          "definition": "An abnormally increased level of immunoglobulin A in blood. [HPO:probinson]",
          "aliases": [
            "increased iga",
            "raised iga",
            "high immunoglobulins",
            "Increased serum IgA",
            "iga elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0234708",
          "score": 0.744,
          "definition": "Increased pressure of the intraocular fluid in the eye.",
          "aliases": [
            "INTRAOCULAR PRESSURE INCREASED",
            "TENSION OCULAR INCREASED",
            "INTRAOCULAR PRESSURE INCREASE",
            "PRESSURE INTRAOCULAR INCREASED",
            "raised intraocular pressure"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_88",
      "canonical_id": "ent_22",
      "text": "AST",
      "label": "ENTITY",
      "start_char": 1733,
      "end_char": 1736,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0004002",
          "score": 0.998,
          "definition": "Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.",
          "aliases": [
            "s-asat",
            "Glutamic oxaloacetic transaminase (GOT)",
            "Aspartate Aminotransferases",
            "glutamic oxaloacetic transaminase",
            "Glutamic Oxaloacetic Transaminase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415181",
          "score": 0.998,
          "definition": "This gene plays a role in amino acid metabolism, the tricarboxylic acid cycle and the urea cycle.",
          "aliases": [
            "glutamate oxaloacetate transaminase 1",
            "glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)",
            "GOT1 Gene",
            "GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE",
            "glutamic-oxaloacetic transaminase 1"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1420113",
          "score": 0.998,
          "definition": null,
          "aliases": [
            "sialic acid storage disease",
            "SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5",
            "NSD",
            "solute carrier family 17 member 5",
            "SIASD"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724380",
          "score": 0.998,
          "definition": "A West Iberian Romance language spoken in the Principality of Asturias, Spain.",
          "aliases": [
            "AST",
            "Asturian Language",
            "Bable",
            "Asturian"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_89",
      "canonical_id": "ent_28",
      "text": "ALT",
      "label": "ENTITY",
      "start_char": 1737,
      "end_char": 1740,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0001899",
          "score": 0.991,
          "definition": "An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.",
          "aliases": [
            "alanine transaminase",
            "transaminase glutamic-pyruvic",
            "Glutamate pyruvate transaminase",
            "ALAT - alanine aminotransferase",
            "Transaminase, Glutamic-Pyruvic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1370889",
          "score": 0.991,
          "definition": "An atypical lipomatous tumor/well differentiated liposarcoma composed of mature adipocytes in which, unlike in benign lipoma, substantial variation in cell size is appreciated alongside nuclear atypia in fat cells or stromal spindle cells. (WHO 2020)",
          "aliases": [
            "Atypical Lipomatous Tumors",
            "Lipomatous Tumor, Atypical",
            "Liposarcoma, well differentiated (morphologic abnormality)",
            "Atypical lipoma",
            "ALT"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2257651",
          "score": 0.991,
          "definition": "Catalysis of the reaction: 2-oxoglutarate + L-alanine = L-glutamate + pyruvate. [EC:2.6.1.2, RHEA:19453]",
          "aliases": [
            "alanine aminotransferase activity",
            "GPT",
            "glutamic acid-pyruvic acid transaminase activity",
            "pyruvate-alanine aminotransferase activity",
            "glutamic-pyruvic aminotransferase activity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4553172",
          "score": 0.991,
          "definition": "The use of a highly concentrated antibiotic solution for the to treatment of catheter-related bloodstream infections.",
          "aliases": [
            "Antibiotic Lock Therapy",
            "ALT"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4724507",
          "score": 0.991,
          "definition": "A Turkic language, spoken officially in the Altai Republic of Russia.",
          "aliases": [
            "Gorno-Altay",
            "Southern Altai Language",
            "Gorno-Altai",
            "ALT",
            "Southern Altai"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_90",
      "canonical_id": "ent_29",
      "text": "ratio",
      "label": "ENTITY",
      "start_char": 1741,
      "end_char": 1746,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0456603",
          "score": 0.968,
          "definition": "Quotient of quantities of the same kind for different components within the same system.",
          "aliases": [
            "ratios",
            "Ratios",
            "Ratio (property) (qualifier value)",
            "RATIO",
            "Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5447121",
          "score": 0.738,
          "definition": "The ratio of two concentration values.",
          "aliases": [
            "Ratio Concentration"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264679",
          "score": 0.736,
          "definition": "The quotient of the mass concentration of one substance divided by the mass concentration of another substance within the same system.",
          "aliases": [
            "Mass ratio (property)",
            "MRTO",
            "Mass ratio (property) (qualifier value)",
            "Mass Ratio",
            "*Mass Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264675",
          "score": 0.706,
          "definition": "The ratio of the length of time for one event and the length of time for another event.",
          "aliases": [
            "TRTO",
            "Time Ratio",
            "Time ratio (property) (qualifier value)",
            "Time ratio (property)",
            "TRto"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_91",
      "canonical_id": "ent_59",
      "text": "non",
      "label": "ENTITY",
      "start_char": 1765,
      "end_char": 1768,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C1513853",
          "score": 0.979,
          "definition": null,
          "aliases": [
            "NON Mouse",
            "NON"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1518422",
          "score": 0.979,
          "definition": "An operation in which a term denies or inverts the meaning of another term or construction.",
          "aliases": [
            "Negated",
            "Negation",
            "Non-",
            "Not",
            "Non"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_92",
      "canonical_id": "ent_60",
      "text": "histological indicators",
      "label": "ENTITY",
      "start_char": 1769,
      "end_char": 1792,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205462",
          "score": 0.738,
          "definition": "Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.",
          "aliases": [
            "Histological",
            "Histologically",
            "Histologic (qualifier value)",
            "Histologic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2987065",
          "score": 0.715,
          "definition": "An indication as to whether there is a relationship to an individual's medical history.",
          "aliases": [],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_93",
      "canonical_id": "ent_61",
      "text": "cirrhosis",
      "label": "ENTITY",
      "start_char": 1796,
      "end_char": 1805,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0023890",
          "score": 0.977,
          "definition": "Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.",
          "aliases": [
            "Hepatic cirrhosis, NOS",
            "Hepatic cirrhosis",
            "HEPATIC CIRRHOSIS",
            "liver cirrhosis",
            "Liver cirrhosis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1623038",
          "score": 0.977,
          "definition": null,
          "aliases": [
            "Cirrhosis",
            "Cirrhoses"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0023892",
          "score": 0.82,
          "definition": "FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.",
          "aliases": [
            "cirrhosis biliary",
            "BILIARY CIRRHOSIS",
            "Biliary cirrhosis",
            "Cirrhosis, Biliary",
            "Liver Cirrhoses, Biliary"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0034069",
          "score": 0.819,
          "definition": "A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.",
          "aliases": [
            "Cirrhosis of lung",
            "lung fibrosis",
            "lung cirrhosis",
            "fibrosis of lung",
            "Lung fibrosis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1622502",
          "score": 0.814,
          "definition": "A nutritional cirrhosis that is characterized by an increase in connective tissue surrounding the portal spaces.",
          "aliases": [
            "Laennec's cirrhosis",
            "Portal cirrhosis, NOS",
            "laennec's cirrhosis",
            "cirrhosis laennecs's",
            "PC - Portal cirrhosis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_94",
      "canonical_id": "ent_58",
      "text": "PBC",
      "label": "ENTITY",
      "start_char": 1809,
      "end_char": 1812,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0008312",
          "score": 0.994,
          "definition": "An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.",
          "aliases": [
            "PRIMARY BILIARY CIRRHOSIS",
            "Primary biliary cholangitis (disorder)",
            "primary biliary cirrhosis",
            "Primary Biliary Cirrhosis",
            "Chronic non-suppurative destructive cholangitis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_95",
      "canonical_id": "ent_62",
      "text": "low",
      "label": "ENTITY",
      "start_char": 1840,
      "end_char": 1843,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205251",
          "score": 0.994,
          "definition": "A minimum level or position or degree; less than normal in degree, intensity or amount.",
          "aliases": [
            "Low (qualifier value)",
            "low",
            "Low"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1550472",
          "score": 0.994,
          "definition": "<p>Privacy metadata indicating that a low level of protection is required to safeguard personal and healthcare information, which has been altered in such a way as to minimize the need for confidentiality protections with some residual risks associated with re-linking. The risk of harm to an individual's reputation and sense of privacy if disclosed without authorization is considered negligible, and mitigations are in place to address reidentification risk.</p><i>Usage Note:</i><p>The level of protection afforded anonymized and pseudonymized, and non-personally identifiable information (e.g., a limited data set) is dictated by privacy policies and data use agreements intended to engender trust that health information can be used and disclosed with little or no risk of re-identification.</p><b>Example:</b>Personal and healthcare information, which excludes 16 designated categories of direct identifiers in a HIPAA Limited Data Set. This information may be disclosed by HIPAA Covered Entities without patient authorization for a research, public health, and operations purposes if conditions are met, which includes obtaining a signed data use agreement from the recipient. See 45 CFR Section 164.514.<p>This metadata indicates that the receiver may have an obligation to comply with a data use agreement with the discloser. The discloser may have obligations to comply with policies dictating the methods for de-identification.</p>Confidentiality code total order hierarchy: Low (L) is less protective than<i>V, R, N,</i>and *M*, and subsumes *U*.",
          "aliases": [
            "low"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1611820",
          "score": 0.994,
          "definition": "<p>The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure).</p><p>Synonym: Below low normal</p>",
          "aliases": [
            "Low"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1619811",
          "score": 0.994,
          "definition": "<p>Indicates that the receiver has messages for the sender</p><i>OpenIssue:</i>Description does not make sense relative to name of coding system. Must be reviewed and improved.",
          "aliases": [
            "MessageWaitingPriority",
            "Low"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4048187",
          "score": 0.994,
          "definition": "<b>Description:</b>Exposure to an agent at a relatively low level above background.",
          "aliases": [
            "low"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "but still only",
          "direction": "FORWARD",
          "scope_phrase": "only achieves a low sensitivity and a specificity of 65-79%.\nAs with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).\nAlcohol"
        }
      ]
    },
    {
      "instance_id": "inst_96",
      "canonical_id": "ent_63",
      "text": "sensitivity",
      "label": "ENTITY",
      "start_char": 1844,
      "end_char": 1855,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0020517",
          "score": 0.997,
          "definition": "Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.",
          "aliases": [
            "Allergic reaction",
            "Sensitivity",
            "hypersensitivity",
            "Hypersensitivity NOS",
            "Hypersensitivity reaction"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0036667",
          "score": 0.997,
          "definition": null,
          "aliases": [
            "statistical sensitivity",
            "Sensitivity",
            "sensitivity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0312418",
          "score": 0.997,
          "definition": null,
          "aliases": [
            "Sensitivity (finding)",
            "emotional sensitivity",
            "sensitivity (personality)",
            "Sensitivity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0427965",
          "score": 0.997,
          "definition": "response of germs to antibiotics treatment",
          "aliases": [
            "Antimicrobial susceptibility - finding",
            "Finding of antimicrobial susceptibility",
            "Sensitivity",
            "antibiotic susceptibility",
            "Antimicrobial susceptibility"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1511883",
          "score": 0.997,
          "definition": "The probability that a test will produce a true postive result when used on effected subjects as compared to a reference or \"gold standard\". The sensitivity of a test can be determined by calculating: number of true positive results divided by the sum of true positive results plus number of false negative results.",
          "aliases": [
            "Diagnostic Sensitivity",
            "Sensitivity",
            "Sensitivity of Diagnostic Test"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "but still only",
          "direction": "FORWARD",
          "scope_phrase": "only achieves a low sensitivity and a specificity of 65-79%.\nAs with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).\nAlcohol"
        }
      ]
    },
    {
      "instance_id": "inst_97",
      "canonical_id": "ent_64",
      "text": "specificity",
      "label": "ENTITY",
      "start_char": 1862,
      "end_char": 1873,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0037791",
          "score": 0.984,
          "definition": null,
          "aliases": [
            "Specificity",
            "specificity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1511884",
          "score": 0.984,
          "definition": "The probability that a test will produce a true negative result when used on non-effected subjects as compared to a reference or \"gold standard\". The specificity of a test can be determined by calculating: number of true negative results divided by the sum of true negative results plus number of false positive results.",
          "aliases": [
            "Specificity of Diagnostic Test",
            "Diagnostic Specificity",
            "Specificity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0037783",
          "score": 0.878,
          "definition": "The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.",
          "aliases": [
            "Species Specificities",
            "Specificity, Species",
            "Specificities, Species"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2936412",
          "score": 0.842,
          "definition": "The properties of a pathogen that makes it capable of infecting one or more specific hosts. The pathogen can include PARASITES as well as VIRUSES; BACTERIA; FUNGI; or PLANTS.",
          "aliases": [
            "Host Species Specificities",
            "Specificity, Host Species",
            "Specificities, Host",
            "Specificities, Host Species",
            "Host Species Specificity"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0029213",
          "score": 0.817,
          "definition": "Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen.",
          "aliases": [
            "Specificity, Organ",
            "Organ Specificities",
            "Specificities, Organ"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "but still only",
          "direction": "FORWARD",
          "scope_phrase": "only achieves a low sensitivity and a specificity of 65-79%.\nAs with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).\nAlcohol"
        }
      ]
    },
    {
      "instance_id": "inst_98",
      "canonical_id": "ent_58",
      "text": "PBC",
      "label": "ENTITY",
      "start_char": 1893,
      "end_char": 1896,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0008312",
          "score": 0.994,
          "definition": "An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.",
          "aliases": [
            "PRIMARY BILIARY CIRRHOSIS",
            "Primary biliary cholangitis (disorder)",
            "primary biliary cirrhosis",
            "Primary Biliary Cirrhosis",
            "Chronic non-suppurative destructive cholangitis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "but still only",
          "direction": "FORWARD",
          "scope_phrase": "only achieves a low sensitivity and a specificity of 65-79%.\nAs with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).\nAlcohol"
        }
      ]
    },
    {
      "instance_id": "inst_99",
      "canonical_id": "ent_65",
      "text": "liver enzymes",
      "label": "ENTITY",
      "start_char": 1898,
      "end_char": 1911,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C1287351",
          "score": 0.975,
          "definition": null,
          "aliases": [
            "enzymes levels liver",
            "liver enzyme level",
            "enzymes level liver",
            "Finding of liver enzyme levels (finding)",
            "enzyme level liver"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "but still only",
          "direction": "FORWARD",
          "scope_phrase": "only achieves a low sensitivity and a specificity of 65-79%.\nAs with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).\nAlcohol"
        }
      ]
    },
    {
      "instance_id": "inst_100",
      "canonical_id": "ent_66",
      "text": "diagnosis",
      "label": "ENTITY",
      "start_char": 1935,
      "end_char": 1944,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0011900",
          "score": 0.98,
          "definition": "The determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process.",
          "aliases": [
            "diagnosing",
            "Diagnosis (observable entity)",
            "Diagnostic",
            "diagnosis",
            "diagnoses"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0945731",
          "score": 0.98,
          "definition": null,
          "aliases": [
            "Diagnosis:Imp:Pt:^Patient:Nom",
            "Dx",
            "Diagnosis",
            "Diagnosis:Impression/interpretation of study:To identify measures at a point in time:^Patient:Nominal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1546899",
          "score": 0.98,
          "definition": null,
          "aliases": [
            "Diagnosis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1704338",
          "score": 0.98,
          "definition": "Used with diseases for all aspects of diagnosis, including examination, differential diagnosis and prognosis. Excludes diagnosis using imaging techniques (e.g. radiography, scintigraphy, and ultrasonography) for which \"diagnostic imaging\" is used.",
          "aliases": [
            "diagnosis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0011914",
          "score": 0.881,
          "definition": "Examination of the mouth and teeth toward the identification and diagnosis of intraoral disease or manifestation of non-oral conditions.",
          "aliases": [
            "Diagnoses, Oral",
            "Oral Diagnoses",
            "Oral Diagnosis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "but still only",
          "direction": "FORWARD",
          "scope_phrase": "only achieves a low sensitivity and a specificity of 65-79%.\nAs with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).\nAlcohol"
        }
      ]
    },
    {
      "instance_id": "inst_101",
      "canonical_id": "ent_67",
      "text": "Primary Sclerosing Cholangitis",
      "label": "ENTITY",
      "start_char": 1948,
      "end_char": 1978,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0566602",
          "score": 0.988,
          "definition": "A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.",
          "aliases": [
            "Cholangitides, Primary Sclerosing",
            "Primary Sclerosing Cholangitis",
            "Cholangitis, Primary Sclerosing",
            "Primary Sclerosing Cholangitides",
            "sclerosing cholangitis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0008313",
          "score": 0.856,
          "definition": "Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.",
          "aliases": [
            "Sclerosing Cholangitides",
            "Sclerosing Cholangiitis",
            "Fibrous cholangitis",
            "Sclerosing cholangitis (disorder)",
            "CHOLANGITIS, OBLITERATIVE, CHRONIC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0400978",
          "score": 0.757,
          "definition": "A rare, biliary tract disease characterized by development of sclerosing cholangitis due to a known primary insult to the biliary tree, including infections, autoimmune disease, exposure to toxic agents, obstructive and ischemic injuries. Patients may be initially asymptomatic with only elevated alkaline phosphatase and gamma glutamyltransferase levels. Later presentation includes abdominal pain, jaundice, pruritus, fever and bacterial cholangitis from ascending infection.",
          "aliases": [
            "Secondary sclerosing cholangitis (disorder)",
            "Secondary sclerosing cholangitis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5680117",
          "score": 0.741,
          "definition": "A rare hepatic disease characterized by the overlap of primary biliary cholangitis and/or primary sclerosing cholangitis with autoimmune hepatitis, defined by the presence of at least two of the three recognized biochemical, serological, and histological criteria of each disease. The onset of the overlapping diseases can be simultaneous or sequential, with a variable interval of up to several years. Age of onset, gender predisposition, and clinical phenotype vary between each of the diseases, and the clinical presentation ranges from asymptomatic disease or unspecific symptoms such as fatigue, arthralgia, and pruritus, to established cirrhosis and decompensation, or also acute, fulminant hepatitis and liver failure. Association with extrahepatic autoimmune diseases is common.",
          "aliases": [
            "PBC/PSC and AIH overlap syndrome",
            "Primary biliary cholangitis and/or primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome (disorder)",
            "Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome",
            "Overlap syndrome of autoimmune liver disease",
            "Overlap syndromes of autoimmune liver diseases"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "but still only",
          "direction": "FORWARD",
          "scope_phrase": "only achieves a low sensitivity and a specificity of 65-79%.\nAs with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).\nAlcohol"
        }
      ]
    },
    {
      "instance_id": "inst_102",
      "canonical_id": "ent_68",
      "text": "PSC",
      "label": "ENTITY",
      "start_char": 1980,
      "end_char": 1983,
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0566602",
          "score": 0.969,
          "definition": "A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.",
          "aliases": [
            "Cholangitides, Primary Sclerosing",
            "Primary Sclerosing Cholangitis",
            "Cholangitis, Primary Sclerosing",
            "Primary Sclerosing Cholangitides",
            "sclerosing cholangitis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0858617",
          "score": 0.969,
          "definition": "A type of cataract that forms in the most posterior cortical layer of the lens, directly under the lens capsule. This type of cataract tends to occur in younger patients than cortical or nuclear sclerotic cataracts.",
          "aliases": [
            "Early-onset posterior polar cataract",
            "Cataract, posterior subcapsular",
            "Posterior subcapsular cataract (disorder)",
            "PSC - posterior subcapsular cataract",
            "Posterior Subcapsular Cataract"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2936598",
          "score": 0.969,
          "definition": "Star-shaped, myofibroblast-like cells located in the periacinar, perivascular, and periductal regions of the EXOCRINE PANCREAS. They play a key role in the pathobiology of FIBROSIS; PANCREATITIS; and PANCREATIC CANCER.",
          "aliases": [
            "Cell, Pancreatic Stellate",
            "Pancreatic Stellate Cell",
            "PSC",
            "Pancreatic Stellate Cells",
            "PaSCs"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "UNCERTAINTY",
          "trigger_phrase": "but still only",
          "direction": "FORWARD",
          "scope_phrase": "only achieves a low sensitivity and a specificity of 65-79%.\nAs with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).\nAlcohol"
        }
      ]
    },
    {
      "instance_id": "inst_103",
      "canonical_id": "ent_69",
      "text": "Alcohol",
      "label": "ENTITY",
      "start_char": 1986,
      "end_char": 1993,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0001962",
          "score": 0.988,
          "definition": "A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.",
          "aliases": [
            "alcohol",
            "\u00c4thylalkohol",
            "ETOH",
            "Methylcarbinol",
            "ethanols"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001975",
          "score": 0.988,
          "definition": "Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)",
          "aliases": [
            "Alcohol",
            "Alcohol, NOS",
            "class of chemical alcohols",
            "alcohols (chemical class)",
            "alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1547288",
          "score": 0.988,
          "definition": null,
          "aliases": [
            "Alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001948",
          "score": 0.862,
          "definition": "Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.",
          "aliases": [
            "Alcohol Consumption",
            "drinking",
            "Drinking",
            "Alcohol Intake",
            "Drinking Habit, Alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001973",
          "score": 0.845,
          "definition": "A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)",
          "aliases": [
            "dependence alcoholism alcohol",
            "Alcoholism (disorder)",
            "ALCOHOLISM",
            "Alcohol dependence",
            "Alcoholism, NOS"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_104",
      "canonical_id": "ent_70",
      "text": "induces",
      "label": "ENTITY",
      "start_char": 1994,
      "end_char": 2001,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205263",
          "score": 0.771,
          "definition": "The act of bringing about something.",
          "aliases": [
            "Inducible",
            "Inducing",
            "Induce",
            "Induced",
            "Induction"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3898767",
          "score": 0.735,
          "definition": "A chemical or physical agent that turns on gene expression.",
          "aliases": [],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_105",
      "canonical_id": "ent_71",
      "text": "hepatic enzymes",
      "label": "ENTITY",
      "start_char": 2002,
      "end_char": 2017,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0428321",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "enzymes levels liver",
            "liver enzyme level",
            "enzymes level liver",
            "hepatic enzyme",
            "enzyme level liver"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_106",
      "canonical_id": "ent_3",
      "text": "raised",
      "label": "ENTITY",
      "start_char": 2031,
      "end_char": 2037,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0442818",
          "score": 0.968,
          "definition": null,
          "aliases": [
            "Raised (qualifier value)",
            "Raised",
            "raised"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0178415",
          "score": 0.772,
          "definition": "The amount of prostate specific antigen is increased, based on pre-defined thresholds.",
          "aliases": [
            "Raised prostate specific antigen (finding)",
            "Elevated prostate specific antigen",
            "increased psa",
            "increasing psa",
            "PSA Elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0239984",
          "score": 0.772,
          "definition": "An abnormally increased level of immunoglobulin A in blood. [HPO:probinson]",
          "aliases": [
            "increased iga",
            "raised iga",
            "high immunoglobulins",
            "Increased serum IgA",
            "iga elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0234708",
          "score": 0.744,
          "definition": "Increased pressure of the intraocular fluid in the eye.",
          "aliases": [
            "INTRAOCULAR PRESSURE INCREASED",
            "TENSION OCULAR INCREASED",
            "INTRAOCULAR PRESSURE INCREASE",
            "PRESSURE INTRAOCULAR INCREASED",
            "raised intraocular pressure"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_107",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 2038,
      "end_char": 2041,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_108",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 2050,
      "end_char": 2053,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_109",
      "canonical_id": "ent_17",
      "text": "normal",
      "label": "ENTITY",
      "start_char": 2067,
      "end_char": 2073,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0205307",
          "score": 0.98,
          "definition": "In pathology, a term that is used to describe a tissue specimen that has a normal appearance.",
          "aliases": [
            "Normal (qualifier value)",
            "unremarkable",
            "normal",
            "Unremarkable",
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1550457",
          "score": 0.98,
          "definition": "<p>The result or observation value is within the reference range or expected norm (as defined for the respective test procedure).</p><p>\\[Note: Applies to numeric or non-numeric results.\\]</p>",
          "aliases": [
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1550469",
          "score": 0.98,
          "definition": "<p>Privacy metadata indicating the level of protection required to safeguard personal and healthcare information, which if disclosed without authorization, would present a considerable risk of harm to an individual's reputation and sense of privacy.</p><i>Usage Note:</i>The level of protection afforded normatively confidential information is dictated by the prevailing normative privacy policies, which are intended to engender patient trust in their healthcare providers.<p>Privacy policies mandating normative levels of protection, which preempt less protective privacy policies when the information is used in the delivery and management of healthcare. May be pre-empted by jurisdictional law (e.g., for public health reporting or emergency treatment).</p><p>Confidentiality code total order hierarchy: Normal (N) is less protective than *V* and *R*, and subsumes all other protection levels (i.e., *M, L, and U*).</p><p>**Map:**Partial Map to ISO 13606-4 Sensitivity Level (3) Clinical Care when purpose of use is treatment: Default for normal clinical care access (i.e., most clinical staff directly caring for the patient should be able to access nearly all of the EHR). Maps to normal confidentiality for treatment information but not to ancillary care, payment and operations.</p><b>Examples:</b><p>n the US, this includes what HIPAA identifies as protected health information (PHI) under 45 CFR Section 160.103.</p>",
          "aliases": [
            "normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1551394",
          "score": 0.98,
          "definition": "<p>No Corrective Action Needed</p>",
          "aliases": [
            "Normal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1553386",
          "score": 0.98,
          "definition": "<p>Encompasses the expected states of an Act, but excludes \"nullified\" and \"obsolete\" which represent unusual terminal states for the life-cycle.</p>",
          "aliases": [
            "normal"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "POSSIBLE_EXISTENCE",
          "trigger_phrase": "may be normal",
          "direction": "FORWARD",
          "scope_phrase": "normal, or disproportionately lower than the GGT.\nA"
        }
      ]
    },
    {
      "instance_id": "inst_110",
      "canonical_id": "ent_72",
      "text": "disproportionately",
      "label": "ENTITY",
      "start_char": 2078,
      "end_char": 2096,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0426415",
          "score": 0.8,
          "definition": "Distance between subnasale and pronasale more than two standard deviations above the mean, or alternatively, an apparently increased anterior protrusion of the nasal tip. [PMID:19152422]",
          "aliases": [
            "Big nose",
            "Increased size of nose",
            "Large nose (finding)",
            "Increased nasal size",
            "Prominent nose"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1849075",
          "score": 0.777,
          "definition": "Head circumference is less than two standard deviations above the mean, but appears disproportionately large when other factors such as stature are considered.",
          "aliases": [
            "Disproportionately large head",
            "Relative macrocephaly (finding)",
            "Macrocephaly, relative",
            "Relatively large head",
            "Relative macrocephaly"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1848109",
          "score": 0.767,
          "definition": "Disproportionately long fibulae. [HPO:probinson]",
          "aliases": [
            "Disproportionately long fibulae",
            "Long fibulae",
            "Long calf bone",
            "Long fibula",
            "Disproportionately long fibula"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1848108",
          "score": 0.754,
          "definition": "Increased length of the ulna. [HPO:probinson]",
          "aliases": [
            "Long ulnae",
            "Disproportionately long ulnae"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0576225",
          "score": 0.752,
          "definition": "Increased back to front length of the foot. [UHPO:probinson]",
          "aliases": [
            "Long foot",
            "Long feet",
            "large feet",
            "Disproportionately large feet",
            "Large feet"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "POSSIBLE_EXISTENCE",
          "trigger_phrase": "may be normal",
          "direction": "FORWARD",
          "scope_phrase": "normal, or disproportionately lower than the GGT.\nA"
        }
      ]
    },
    {
      "instance_id": "inst_111",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 2112,
      "end_char": 2115,
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "POSSIBLE_EXISTENCE",
          "trigger_phrase": "may be normal",
          "direction": "FORWARD",
          "scope_phrase": "normal, or disproportionately lower than the GGT.\nA"
        }
      ]
    },
    {
      "instance_id": "inst_112",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 2119,
      "end_char": 2122,
      "sentence_text": "A GGT: ALP ratio > 2.5 in association with jaundice suggests alcohol as a cause of liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_113",
      "canonical_id": "ent_5",
      "text": "ALP",
      "label": "ENTITY",
      "start_char": 2124,
      "end_char": 2127,
      "sentence_text": "A GGT: ALP ratio > 2.5 in association with jaundice suggests alcohol as a cause of liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0002059",
          "score": 0.973,
          "definition": "An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.",
          "aliases": [
            "Alkaline phosphatase",
            "ALKALINE PHOSPHATASE",
            "Orthophosphoric-monoester phosphohydrolase (alkaline optimum)",
            "AP - Alkaline phosphatase",
            "glycerophosphatase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0663932",
          "score": 0.973,
          "definition": "Antileukoproteinase (132 aa, ~14 kDa) is encoded by the human SLPI gene. This protein is involved in the regulation of serine proteinase activity.",
          "aliases": [
            "secretory leukocyte protease inhibitor protein, human",
            "Protease Inhibitor WAP4",
            "MPI",
            "Secretory Leukocyte Protease Inhibitor",
            "secretory leukocyte protease inhibitor receptor, human"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366565",
          "score": 0.973,
          "definition": "This gene is involved in the immune response.",
          "aliases": [
            "WAP4",
            "ANTILEUKOPROTEASE",
            "antileukoproteinase",
            "ALK1",
            "WFDC4"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1366566",
          "score": 0.973,
          "definition": "This gene is involved in immunoregulation.",
          "aliases": [
            "ESkine",
            "IL-11 Ralpha-locus chemokine",
            "cutaneous T-cell attracting chemokine",
            "CTAK",
            "CC chemokine ILC"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1424288",
          "score": 0.973,
          "definition": null,
          "aliases": [
            "asparaginase and isoaspartyl peptidase 1",
            "ALP",
            "FLJ22316",
            "ASPARAGINASE 3",
            "ASRGL1"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_114",
      "canonical_id": "ent_29",
      "text": "ratio",
      "label": "ENTITY",
      "start_char": 2128,
      "end_char": 2133,
      "sentence_text": "A GGT: ALP ratio > 2.5 in association with jaundice suggests alcohol as a cause of liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0456603",
          "score": 0.968,
          "definition": "Quotient of quantities of the same kind for different components within the same system.",
          "aliases": [
            "ratios",
            "Ratios",
            "Ratio (property) (qualifier value)",
            "RATIO",
            "Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5447121",
          "score": 0.738,
          "definition": "The ratio of two concentration values.",
          "aliases": [
            "Ratio Concentration"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264679",
          "score": 0.736,
          "definition": "The quotient of the mass concentration of one substance divided by the mass concentration of another substance within the same system.",
          "aliases": [
            "Mass ratio (property)",
            "MRTO",
            "Mass ratio (property) (qualifier value)",
            "Mass Ratio",
            "*Mass Ratio"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1264675",
          "score": 0.706,
          "definition": "The ratio of the length of time for one event and the length of time for another event.",
          "aliases": [
            "TRTO",
            "Time Ratio",
            "Time ratio (property) (qualifier value)",
            "Time ratio (property)",
            "TRto"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_115",
      "canonical_id": "ent_73",
      "text": "association",
      "label": "ENTITY",
      "start_char": 2143,
      "end_char": 2154,
      "sentence_text": "A GGT: ALP ratio > 2.5 in association with jaundice suggests alcohol as a cause of liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0004083",
          "score": 0.967,
          "definition": "A functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established.",
          "aliases": [
            "Association",
            "mental association",
            "Associations",
            "association",
            "association [mental function]"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0439849",
          "score": 0.967,
          "definition": "A state of connectedness between people, objects, or events; to be associated or connected with something.",
          "aliases": [
            "Relationships (qualifier value)",
            "Relationship",
            "Association",
            "relationships",
            "Relationships"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0596306",
          "score": 0.967,
          "definition": "Any process of combining chemical entities that is dependent upon chemical forces.",
          "aliases": [
            "chemical association",
            "Chemical Association",
            "Association",
            "Chemical Linkage"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0699792",
          "score": 0.967,
          "definition": null,
          "aliases": [
            "association"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1704770",
          "score": 0.967,
          "definition": "An association is a non-hierarchical, named relationship between a source and target concept that does not affect classification and is not inherited by child concepts during classification. Associations are bidirectional and have a stated inverse. Unlike roles, associations do not have a domain or range.",
          "aliases": [
            "NCI Thesaurus Association",
            "Association"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_116",
      "canonical_id": "ent_74",
      "text": "jaundice",
      "label": "ENTITY",
      "start_char": 2160,
      "end_char": 2168,
      "sentence_text": "A GGT: ALP ratio > 2.5 in association with jaundice suggests alcohol as a cause of liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0022346",
          "score": 0.947,
          "definition": "A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.",
          "aliases": [
            "jaundice",
            "YELLOW SKIN",
            "Jaundice (finding)",
            "icteric",
            "Yellow skin"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4764276",
          "score": 0.815,
          "definition": "A clinical assessment or impression by direct observation indicating whether or not a patient has a condition of jaundice (is jaundiced).",
          "aliases": [
            "Jaundice present or absent",
            "Jaundice Status (Present or Absent)",
            "Jaundice positive or negative"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0179301",
          "score": 0.804,
          "definition": "Bilirubinometers that measure the concentration of bilirubin in neonate blood through the skin. A light beam is applied to the newborn's skin, usually on the forehead or sternum, and the reflected light is split into two beams (with wavelengths of 455 nm and 575 nm), which are measured by optical detectors. The blood bilirubin concentration can be derived from the measured light absorbance.",
          "aliases": [
            "Transcutaneous Jaundice Meters",
            "Indirect Bilirubinometers",
            "Jaundice Meters",
            "METER, JAUNDICE",
            "Cutaneous Bilirubinometers"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0240962",
          "score": 0.784,
          "definition": "Yellowing of the white part of the eyes, often due to a rise in bilirubin levels.",
          "aliases": [
            "Conjunctival icterus",
            "scleral icterus",
            "sclera yellowing",
            "Yellow sclera",
            "icteric sclera"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3279964",
          "score": 0.781,
          "definition": "A rare genetic hepatic disease characterized by the presence of green coloration of the skin, urine, plasma and other body fluids (ascites, breastmilk) or parts (sclerae) due to increased serum levels of biliverdin in association with biliary obstruction and/or liver failure. Association with malnutrition, medication, and congenital biliary atresia has also been reported. Can be caused by heterozygous or homozygous mutation in the gene encoding bilirubin reductase-alpha (BLVRA) on chromosome 7p13.",
          "aliases": [
            "Hyperbiliverdinaemia",
            "Hyperbiliverdinemia (disorder)",
            "GREEN JAUNDICE",
            "HBLVD",
            "HYPERBILIVERDINEMIA"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_117",
      "canonical_id": "ent_69",
      "text": "alcohol",
      "label": "ENTITY",
      "start_char": 2178,
      "end_char": 2185,
      "sentence_text": "A GGT: ALP ratio > 2.5 in association with jaundice suggests alcohol as a cause of liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0001962",
          "score": 0.988,
          "definition": "A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.",
          "aliases": [
            "alcohol",
            "\u00c4thylalkohol",
            "ETOH",
            "Methylcarbinol",
            "ethanols"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001975",
          "score": 0.988,
          "definition": "Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)",
          "aliases": [
            "Alcohol",
            "Alcohol, NOS",
            "class of chemical alcohols",
            "alcohols (chemical class)",
            "alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1547288",
          "score": 0.988,
          "definition": null,
          "aliases": [
            "Alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001948",
          "score": 0.862,
          "definition": "Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.",
          "aliases": [
            "Alcohol Consumption",
            "drinking",
            "Drinking",
            "Alcohol Intake",
            "Drinking Habit, Alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001973",
          "score": 0.845,
          "definition": "A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)",
          "aliases": [
            "dependence alcoholism alcohol",
            "Alcoholism (disorder)",
            "ALCOHOLISM",
            "Alcohol dependence",
            "Alcoholism, NOS"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_118",
      "canonical_id": "ent_75",
      "text": "liver disease",
      "label": "ENTITY",
      "start_char": 2200,
      "end_char": 2213,
      "sentence_text": "A GGT: ALP ratio > 2.5 in association with jaundice suggests alcohol as a cause of liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0023895",
          "score": 0.984,
          "definition": "Pathological processes of the LIVER.",
          "aliases": [
            "HEPATIC DISEASE",
            "Liver diseases",
            "LD - Liver disease",
            "Hepatic disease",
            "DISEASES OF THE LIVER"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0267792",
          "score": 0.984,
          "definition": "A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.",
          "aliases": [
            "Liver and Biliary System Disorder",
            "DISEASES OF THE LIVER AND BILIARY SYSTEM",
            "Hepatobiliary Disorder",
            "hepatobiliary disease",
            "Liver and Biliary Disorder"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0011119",
          "score": 0.812,
          "definition": "A condition occurring as a result of exposure to a rapid fall in ambient pressure. Gases, nitrogen in particular, come out of solution and form bubbles in body fluid and blood. These gas bubbles accumulate in joint spaces and the peripheral circulation impairing tissue oxygenation causing disorientation, severe pain, and potentially death.",
          "aliases": [
            "bend",
            "CHOKES",
            "AEROBULLOSIS",
            "decompression sickness",
            "DIVER DISEASE"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0158683",
          "score": 0.797,
          "definition": "A usually asymptomatic hereditary disorder which is often associated with polycystic kidney disease. It is characterized by the presence of fluid-filled biliary cysts throughout the liver.",
          "aliases": [
            "cystic diseases liver",
            "cystic liver disease",
            "Polycystic liver disease",
            "Polycystic Liver Disease",
            "cystic disease of liver"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0341439",
          "score": 0.783,
          "definition": "Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests.",
          "aliases": [
            "Chronic hepatopathy",
            "Chronic Liver Disease",
            "liver disease chronic",
            "HEPATIC: CHRONIC",
            "chronic hepatic"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_119",
      "canonical_id": "ent_76",
      "text": "presence",
      "label": "ENTITY",
      "start_char": 2219,
      "end_char": 2227,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0392148",
          "score": 0.991,
          "definition": null,
          "aliases": [
            "presence",
            "presences",
            "Providing presence",
            "Providing presence (regime/therapy)",
            "Presence"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3854307",
          "score": 0.991,
          "definition": null,
          "aliases": [
            "Pr",
            "Presence",
            "Presence (property) (qualifier value)",
            "Presence (property)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0150312",
          "score": 0.935,
          "definition": "Being or existing in a specified place or at the specified time.",
          "aliases": [
            "present",
            "of presence",
            "Found",
            "Present",
            "Presence of"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1553522",
          "score": 0.739,
          "definition": "<p>Participation by direct action where subject and actor are in separate locations, and the actions of the actor are transmitted by electronic or mechanical means. (The participation involves more than communication.)</p>",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C0449450",
          "score": 0.706,
          "definition": "To show or display; the act of presenting something to sight or view: how something looks.",
          "aliases": [
            "Presented",
            "presentations",
            "Presentation (attribute)",
            "Present",
            "Presentation"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_120",
      "canonical_id": "ent_77",
      "text": "macrocytosis",
      "label": "ENTITY",
      "start_char": 2233,
      "end_char": 2245,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0085662",
          "score": 0.989,
          "definition": null,
          "aliases": [
            "macrocythemia",
            "macrocytosis",
            "Macrocytosis",
            "MACROCYTOSIS"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0684332",
          "score": 0.989,
          "definition": null,
          "aliases": [
            "megalocyte",
            "macrocytosis",
            "Macrocytosis",
            "Macrocytosis, red cells",
            "Enlarged red blood cells"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C2004480",
          "score": 0.989,
          "definition": "An increase in nuclear size and amount of cytoplasm of a cell. The cells or nucleus may be slightly irregular and/or may be polyploid.",
          "aliases": [
            "megalocytosis",
            "Macrocytosis",
            "Macrocytosis (morphologic abnormality)",
            "Megalocytosis",
            "Karyocytomegaly"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C5209286",
          "score": 0.847,
          "definition": "Enlarged, oval-shaped erythrocytes (red blood cells). [ORCID:0000-0001-9969-8610, PMID:16988104, PMID:19202968, PMID:28821482]",
          "aliases": [],
          "snomed_ids": []
        },
        {
          "cui": "C3271951",
          "score": 0.797,
          "definition": "An endocytosis process that results in the uptake of liquid material by cells from their external environment by the 'ruffling' of the cell membrane to form heterogeneously sized intracellular vesicles called macropinosomes, which can be up to 5 micrometers in size. [PMID:14732047]",
          "aliases": [],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_121",
      "canonical_id": "ent_78",
      "text": "associated",
      "label": "ENTITY",
      "start_char": 2264,
      "end_char": 2274,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0332281",
          "score": 0.986,
          "definition": "Joined in some kind of relationship.",
          "aliases": [
            "AW",
            "associating",
            "Associated with (attribute)",
            "associated with",
            "Associated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1706221",
          "score": 0.853,
          "definition": "A person who is an assistant or subordinate to another professional, e.g. research associate functioning under the general supervision of the appointed investigator.",
          "aliases": [
            "Associate"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0699040",
          "score": 0.853,
          "definition": "The external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm]",
          "aliases": [
            "Surface of cell",
            "cell bound",
            "cell surface",
            "cell associated",
            "Cell Surface"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0036238",
          "score": 0.837,
          "definition": "Defective viruses which can multiply only by association with a helper virus which complements the defective gene. Satellite viruses may be associated with certain plant viruses, animal viruses, or bacteriophages. They differ from satellite RNA; (RNA, SATELLITE) in that satellite viruses encode their own coat protein.",
          "aliases": [
            "associated virus",
            "satellites",
            "Associated Virus",
            "Satellite Virus",
            "virus associated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0004083",
          "score": 0.762,
          "definition": "A functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established.",
          "aliases": [
            "Association",
            "mental association",
            "Associations",
            "association",
            "association [mental function]"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_122",
      "canonical_id": "ent_79",
      "text": "dietary deficiency",
      "label": "ENTITY",
      "start_char": 2275,
      "end_char": 2293,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0162429",
          "score": 0.986,
          "definition": "An imbalanced nutritional status resulting from insufficient intake of nutrients to meet normal physiological requirement.",
          "aliases": [
            "nutritional deficiency",
            "deficiencies nutritional",
            "Malnutrition NOS",
            "nutritional deficiencies",
            "Acquired deficiency"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4761312",
          "score": 0.986,
          "definition": "A deficiency of a necessary nutrient.",
          "aliases": [
            "Nutritional deficiency disorder (disorder)",
            "Nutritional deficiency finding",
            "Nutritional deficiency state",
            "nutritional deficiency",
            "Nutritional deficiency, NOS"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1623416",
          "score": 0.759,
          "definition": "Used with endogenous and exogenous substances which are absent or in diminished amount relative to the normal requirement of an organism or a biologic system.",
          "aliases": [
            "deficiency"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4331349",
          "score": 0.738,
          "definition": "Congenital lipoid adrenal hyperplasia (CLAH) due to loss-of-function mutations in the STAR gene, resulting in decreased or absent production of steroidogenic acute regulatory protein (StAR), which leads to deficient transport of cholesterol from the outer to the inner mitochondrial membrane.",
          "aliases": [
            "StAR Deficiency"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0039585",
          "score": 0.716,
          "definition": "A disorder of sexual development transmitted as an X-linked recessive trait. These patients have a karyotype of 46,XY with end-organ resistance to androgen due to mutations in the androgen receptor (RECEPTORS, ANDROGEN) gene. Severity of the defect in receptor quantity or quality correlates with their phenotypes. In these genetic males, the phenotypic spectrum ranges from those with normal female external genitalia, through those with genital ambiguity as in Reifenstein Syndrome, to that of a normal male with INFERTILITY.",
          "aliases": [
            "Androgen Resistance Syndromes",
            "DIHYDROTESTOSTERONE RECEPTOR DEFICIENCY",
            "Morris syndrome",
            "ANDROGEN RECEPTOR DEFICIENCY",
            "TESTICULAR FEMINIZATION SYNDROME"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_123",
      "canonical_id": "ent_80",
      "text": "folate",
      "label": "ENTITY",
      "start_char": 2297,
      "end_char": 2303,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0178638",
          "score": 0.985,
          "definition": "A cofactor for 1-carbon transfer involved with DNA synthesis.",
          "aliases": [
            "folate",
            "folates",
            "Folate"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_124",
      "canonical_id": "ent_81",
      "text": "B12",
      "label": "ENTITY",
      "start_char": 2307,
      "end_char": 2310,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0042845",
          "score": 0.989,
          "definition": "A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues. INTRINSIC FACTOR is important for the assimilation of vitamin B 12.",
          "aliases": [
            "Cyanocobalamin preparation",
            "Product containing cyanocobalamin (medicinal product)",
            "Vitamin B12",
            "Vitamin B-12",
            "Cyanocob(III)alamin"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1417635",
          "score": 0.989,
          "definition": null,
          "aliases": [
            "NDUFB3 gene",
            "NADH:ubiquinone oxidoreductase subunit B3",
            "B12",
            "NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B3",
            "NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1420797",
          "score": 0.989,
          "definition": "This gene plays a role in the regulation of protein ubiquitination.",
          "aliases": [
            "BTBD34",
            "MGC2317",
            "TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 1",
            "TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN, ENDOTHELIAL",
            "EDP1"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3538796",
          "score": 0.989,
          "definition": "Human TNFAIP1 wild-type allele is located within 17q22-q23 and is approximately 11 kb in length. This allele, which encodes BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2, is involved in the modulation of the ubiquitination of transforming protein RhoA.",
          "aliases": [
            "BTBD34",
            "MGC2317",
            "BACURD2",
            "EDP1",
            "hBACURD2"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0086024",
          "score": 0.795,
          "definition": "An essential nutrient and natural water-soluble vitamin of the B-complex family that must combine with an intrinsic factor for absorption by the intestine, Vitamin B12 (cyanocobalamin) is necessary for hematopoiesis, neural metabolism, DNA and RNA production, and carbohydrate, fat, and protein metabolism. B12 improves iron functions in the metabolic cycle and assists folic acid in choline synthesis. B12 metabolism is interconnected with that of folic acid. Vitamin B12 deficiency causes pernicious anemia, megaloblastic anemia, and neurologic lesions.",
          "aliases": [
            "vit B12",
            "Cobalamin preparation, NOS",
            "B12 Vitamin",
            "Vitamin-B12",
            "cobalamin"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_125",
      "canonical_id": "ent_82",
      "text": "suppression",
      "label": "ENTITY",
      "start_char": 2331,
      "end_char": 2342,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0221103",
          "score": 0.982,
          "definition": null,
          "aliases": [
            "Supression of binocular vision",
            "Suppression",
            "Binocular vision suppression (disorder)",
            "Binocular vision suppression",
            "Suppression (observable entity)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0301625",
          "score": 0.982,
          "definition": null,
          "aliases": [
            "metabolic suppression",
            "suppression",
            "Suppression"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0728721",
          "score": 0.982,
          "definition": "conscious inhibition of an unacceptable impulse or idea.",
          "aliases": [
            "psychological suppression",
            "suppression"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1956351",
          "score": 0.849,
          "definition": "Joint gene silencing of extra copies of genes, such as TRANSGENES, along with the original endogenous gene. Cosuppression is induced by the presence of the extra gene copies via mechanisms that are related to RNA INTERFERENCE.",
          "aliases": [
            "Co-Suppression",
            "Cosuppression",
            "Co Suppression"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0546981",
          "score": 0.815,
          "definition": "Active suspension of lactation using a medical or physical intervention.",
          "aliases": [
            "Suppression of lactation",
            "Inhibition of lactation procedure",
            "Inhibition of lactation procedure (procedure)",
            "Suppressing milk",
            "Lactation Suppression"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_126",
      "canonical_id": "ent_83",
      "text": "bone marrow",
      "label": "ENTITY",
      "start_char": 2346,
      "end_char": 2357,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0005953",
          "score": 0.978,
          "definition": "The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.",
          "aliases": [
            "Marrow (bone)",
            "Bone marrow",
            "BONE MARROW",
            "Medulla ossea",
            "hematopoietic marrow"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0005955",
          "score": 0.854,
          "definition": "Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.",
          "aliases": [
            "cell bone marrow",
            "Bone Marrow Cell",
            "Cells, Bone Marrow",
            "Marrow Cell, Bone",
            "bone marrow cells"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0729291",
          "score": 0.837,
          "definition": "Bone marrow in the rib.",
          "aliases": [
            "All bone marrow of a rib",
            "Rib bone marrow",
            "Bone marrow of rib",
            "Bone Marrow, Rib",
            "All bone marrow of a rib (body structure)"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_127",
      "canonical_id": "ent_69",
      "text": "alcohol",
      "label": "ENTITY",
      "start_char": 2361,
      "end_char": 2368,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0001962",
          "score": 0.988,
          "definition": "A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.",
          "aliases": [
            "alcohol",
            "\u00c4thylalkohol",
            "ETOH",
            "Methylcarbinol",
            "ethanols"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001975",
          "score": 0.988,
          "definition": "Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)",
          "aliases": [
            "Alcohol",
            "Alcohol, NOS",
            "class of chemical alcohols",
            "alcohols (chemical class)",
            "alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1547288",
          "score": 0.988,
          "definition": null,
          "aliases": [
            "Alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001948",
          "score": 0.862,
          "definition": "Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.",
          "aliases": [
            "Alcohol Consumption",
            "drinking",
            "Drinking",
            "Alcohol Intake",
            "Drinking Habit, Alcohol"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001973",
          "score": 0.845,
          "definition": "A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)",
          "aliases": [
            "dependence alcoholism alcohol",
            "Alcoholism (disorder)",
            "ALCOHOLISM",
            "Alcohol dependence",
            "Alcoholism, NOS"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_128",
      "canonical_id": "ent_66",
      "text": "diagnosis",
      "label": "ENTITY",
      "start_char": 2390,
      "end_char": 2399,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0011900",
          "score": 0.98,
          "definition": "The determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process.",
          "aliases": [
            "diagnosing",
            "Diagnosis (observable entity)",
            "Diagnostic",
            "diagnosis",
            "diagnoses"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0945731",
          "score": 0.98,
          "definition": null,
          "aliases": [
            "Diagnosis:Imp:Pt:^Patient:Nom",
            "Dx",
            "Diagnosis",
            "Diagnosis:Impression/interpretation of study:To identify measures at a point in time:^Patient:Nominal"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1546899",
          "score": 0.98,
          "definition": null,
          "aliases": [
            "Diagnosis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1704338",
          "score": 0.98,
          "definition": "Used with diseases for all aspects of diagnosis, including examination, differential diagnosis and prognosis. Excludes diagnosis using imaging techniques (e.g. radiography, scintigraphy, and ultrasonography) for which \"diagnostic imaging\" is used.",
          "aliases": [
            "diagnosis"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0011914",
          "score": 0.881,
          "definition": "Examination of the mouth and teeth toward the identification and diagnosis of intraoral disease or manifestation of non-oral conditions.",
          "aliases": [
            "Diagnoses, Oral",
            "Oral Diagnoses",
            "Oral Diagnosis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_129",
      "canonical_id": "ent_84",
      "text": "alcoholic liver disease",
      "label": "ENTITY",
      "start_char": 2403,
      "end_char": 2426,
      "sentence_text": "The presence of a macrocytosis, due to either an associated dietary deficiency of folate or B12, or due to a direct suppression of bone marrow by alcohol is supportive of the diagnosis of alcoholic liver disease.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0023896",
          "score": 0.978,
          "definition": "Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.",
          "aliases": [
            "Alcoholic Liver Diseases",
            "Alcoholic Liver Disease",
            "alcoholic disease liver",
            "ALCOHOLIC LIVER DISEASE",
            "Liver Diseases, Alcoholic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001306",
          "score": 0.888,
          "definition": "Acute hepatitis resulting from ingestion of alcohol.",
          "aliases": [
            "acute alcoholic hepatitis",
            "Acute alcoholic hepatitis",
            "Acute Alcoholic Hepatitis",
            "Acute alcoholic liver disease",
            "Acute alcoholic liver disease (disorder)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0015696",
          "score": 0.839,
          "definition": "Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated.",
          "aliases": [
            "Alcoholic Fatty Liver",
            "Alcoholic fatty liver (disorder)",
            "alcoholic fatty liver",
            "alcohol induced fatty liver",
            "Alcoholic fatty liver"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0400966",
          "score": 0.811,
          "definition": "A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.",
          "aliases": [
            "Nonalcoholic fatty liver disease",
            "Fatty Liver, Nonalcoholic",
            "non-alcoholic fatty liver",
            "Non-alcoholic fatty liver (disorder)",
            "Fatty Livers, Nonalcoholic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0023895",
          "score": 0.744,
          "definition": "Pathological processes of the LIVER.",
          "aliases": [
            "HEPATIC DISEASE",
            "Liver diseases",
            "LD - Liver disease",
            "Hepatic disease",
            "DISEASES OF THE LIVER"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_130",
      "canonical_id": "ent_3",
      "text": "raised",
      "label": "ENTITY",
      "start_char": 2430,
      "end_char": 2436,
      "sentence_text": "A raised GGT is not diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0442818",
          "score": 0.968,
          "definition": null,
          "aliases": [
            "Raised (qualifier value)",
            "Raised",
            "raised"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0178415",
          "score": 0.772,
          "definition": "The amount of prostate specific antigen is increased, based on pre-defined thresholds.",
          "aliases": [
            "Raised prostate specific antigen (finding)",
            "Elevated prostate specific antigen",
            "increased psa",
            "increasing psa",
            "PSA Elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0239984",
          "score": 0.772,
          "definition": "An abnormally increased level of immunoglobulin A in blood. [HPO:probinson]",
          "aliases": [
            "increased iga",
            "raised iga",
            "high immunoglobulins",
            "Increased serum IgA",
            "iga elevated"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0234708",
          "score": 0.744,
          "definition": "Increased pressure of the intraocular fluid in the eye.",
          "aliases": [
            "INTRAOCULAR PRESSURE INCREASED",
            "TENSION OCULAR INCREASED",
            "INTRAOCULAR PRESSURE INCREASE",
            "PRESSURE INTRAOCULAR INCREASED",
            "raised intraocular pressure"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_131",
      "canonical_id": "ent_6",
      "text": "GGT",
      "label": "ENTITY",
      "start_char": 2437,
      "end_char": 2440,
      "sentence_text": "A raised GGT is not diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0017040",
          "score": 0.999,
          "definition": "An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.",
          "aliases": [
            "gamma glutamyltransferase",
            "Transpeptidase, gamma-Glutamyl",
            "Gamma-glutamyltransferase",
            "gamma-glutamyl transpeptidase",
            "gamma Glutamyltransferase"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415053",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GGT1 gene",
            "GGT1",
            "CD224",
            "gamma-glutamyltransferase 1",
            "D22S672"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1415054",
          "score": 0.999,
          "definition": null,
          "aliases": [
            "GAMMA-GLUTAMYLTRANSFERASE 2",
            "gamma-glutamyltransferase 2",
            "gamma-glutamyltransferase 2, pseudogene",
            "GGT2",
            "GGT2P gene"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0202035",
          "score": 0.776,
          "definition": "A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.",
          "aliases": [
            "Gamma Glutamyl Transpeptidase Measurement",
            "Gamma glutamyl transferase measurement (procedure)",
            "GGT measurement",
            "Gamma-glutamyl transferase level",
            "GGTP"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0151662",
          "score": 0.769,
          "definition": "Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.",
          "aliases": [
            "GAMMA-GT INCREASED",
            "increased gamma gt",
            "Gamma-glutamyl transferase raised (finding)",
            "GGTP INC",
            "GAMMA GLUTAMYL TRANSPEPTIDASE INCREASED"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": []
    },
    {
      "instance_id": "inst_132",
      "canonical_id": "ent_85",
      "text": "diagnostic",
      "label": "ENTITY",
      "start_char": 2448,
      "end_char": 2458,
      "sentence_text": "A raised GGT is not diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0011900",
          "score": 0.979,
          "definition": "The determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process.",
          "aliases": [
            "diagnosing",
            "Diagnosis (observable entity)",
            "Diagnostic",
            "diagnosis",
            "diagnoses"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0348026",
          "score": 0.979,
          "definition": "Characteristic or indicative of a condition.",
          "aliases": [
            "Diagnostic intent (qualifier value)",
            "Diagnostic",
            "Diagnostic intent"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0358514",
          "score": 0.979,
          "definition": null,
          "aliases": [
            "agents diagnostic",
            "diagnostic agents",
            "aids diagnostic",
            "Diagnostic Aids",
            "Diagnostic substance (substance)"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1547424",
          "score": 0.979,
          "definition": null,
          "aliases": [
            "Diagnostic"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1511886",
          "score": 0.846,
          "definition": "Clinical evaluation of the utility of diagnostic procedures.",
          "aliases": [
            "Clinical Trials, Diagnosis"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "is not diagnostic",
          "direction": "FORWARD",
          "scope_phrase": "diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.\n    "
        }
      ]
    },
    {
      "instance_id": "inst_133",
      "canonical_id": "ent_86",
      "text": "alcohol abuse",
      "label": "ENTITY",
      "start_char": 2462,
      "end_char": 2475,
      "sentence_text": "A raised GGT is not diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0085762",
          "score": 0.982,
          "definition": "The use of alcoholic beverages to excess, either on individual occasions (\"binge drinking\") or as a regular practice.",
          "aliases": [
            "Alcohol abuse, unspecified drinking behavior",
            "problem drinking",
            "abuses alcohol",
            "Abuse, Ethanol",
            "dysfunctional alcohol use"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0001973",
          "score": 0.882,
          "definition": "A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)",
          "aliases": [
            "dependence alcoholism alcohol",
            "Alcoholism (disorder)",
            "ALCOHOLISM",
            "Alcohol dependence",
            "Alcoholism, NOS"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C4050601",
          "score": 0.867,
          "definition": "A rating scale included in the Behavior Assessment System for Children, College Version, that identifies subjects who engage in drinking behaviors that have the potential to lead to alcohol abuse and those who experience academic, social, or functional problems due to their alcohol consumption.",
          "aliases": [
            "Alcohol Abuse Scale"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1171178",
          "score": 0.866,
          "definition": "Actions performed to avoid, minimize, or control the use of distilled liquors",
          "aliases": [
            "Alcohol abuse prevention (procedure)",
            "Alcohol abuse control",
            "alcohol abuse prevention",
            "Alcohol Abuse Control"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0740858",
          "score": 0.822,
          "definition": "Maladaptive pattern of drug or alcohol use that may lead to social, occupational, psychological, or physical problems.",
          "aliases": [
            "disorder, substance abuse",
            "drug and alcohol abuse",
            "Harmful substance use",
            "Nondependent abuse of substance",
            "harmful Alcohol or Other Drugs use"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "is not diagnostic",
          "direction": "FORWARD",
          "scope_phrase": "diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.\n    "
        }
      ]
    },
    {
      "instance_id": "inst_134",
      "canonical_id": "ent_87",
      "text": "research",
      "label": "ENTITY",
      "start_char": 2482,
      "end_char": 2490,
      "sentence_text": "A raised GGT is not diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0035168",
          "score": 0.986,
          "definition": "Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed)",
          "aliases": [
            "research",
            "Research",
            "inquiry"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0242481",
          "score": 0.986,
          "definition": "Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered.",
          "aliases": [
            "research activities",
            "Research Activities",
            "Research Activity",
            "Activity, Research",
            "research"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1548287",
          "score": 0.986,
          "definition": null,
          "aliases": [
            "Research"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C3245477",
          "score": 0.986,
          "definition": "<p>**Definition:**To provide research data, as authorized by the patient.</p>",
          "aliases": [
            "research"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C1518856",
          "score": 0.837,
          "definition": "Research as to the cause of pain and the treatment thereof",
          "aliases": [],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "is not diagnostic",
          "direction": "FORWARD",
          "scope_phrase": "diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.\n    "
        }
      ]
    },
    {
      "instance_id": "inst_135",
      "canonical_id": "ent_88",
      "text": "former drinkers",
      "label": "ENTITY",
      "start_char": 2518,
      "end_char": 2533,
      "sentence_text": "A raised GGT is not diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0337679",
          "score": 0.72,
          "definition": "An individual who used to drink regularly, but does not drink at the present time.",
          "aliases": [
            "Ex-drinker (finding)",
            "Former alcohol drinker",
            "Ex-Drinker",
            "Ex-drinker"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "is not diagnostic",
          "direction": "FORWARD",
          "scope_phrase": "diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.\n    "
        }
      ]
    },
    {
      "instance_id": "inst_136",
      "canonical_id": "ent_89",
      "text": "drinkers",
      "label": "ENTITY",
      "start_char": 2553,
      "end_char": 2561,
      "sentence_text": "A raised GGT is not diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.",
      "section_title": "UNCATEGORIZED",
      "umls_linking": [
        {
          "cui": "C0556338",
          "score": 0.832,
          "definition": "An individual who drinks at least once per week with regularity.",
          "aliases": [
            "Regular Drinker"
          ],
          "snomed_ids": []
        },
        {
          "cui": "C0457801",
          "score": 0.755,
          "definition": "An individual who does not drink at the present time. This is a heterogeneous group comprising both lifelong teetotallers and ex-drinkers.",
          "aliases": [
            "Never drinks",
            "abstinent",
            "Current non-drinker of alcohol",
            "alcohol does drinking",
            "Teetotaller"
          ],
          "snomed_ids": []
        }
      ],
      "contextual_modifiers": [
        {
          "category": "NEGATED_EXISTENCE",
          "trigger_phrase": "is not diagnostic",
          "direction": "FORWARD",
          "scope_phrase": "diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.\n    "
        }
      ]
    }
  ],
  "sentence_relation_hints": [
    {
      "atom_type": "probabilistic_relation_hint",
      "id": "sent_5",
      "sentence_text": "When due to choledocholithiasis, the levels of ALP and GGT tend to fluctuate (in comparison to stricture forming disease) and may be associated with a normal bilirubin.",
      "start_char": 315,
      "end_char": 484,
      "entities_involved_ids": [
        "inst_16",
        "inst_17",
        "inst_18",
        "inst_19",
        "inst_20",
        "inst_21",
        "inst_22",
        "inst_23",
        "inst_24",
        "inst_25"
      ],
      "uncertainty_triggers": [
        {
          "trigger": "may be associated",
          "category": "POSSIBLE_EXISTENCE"
        }
      ]
    },
    {
      "atom_type": "probabilistic_relation_hint",
      "id": "sent_6",
      "sentence_text": "Enzyme titres tend to rise and fall gradually and may be preceded by a peaked rise in liver transaminases which can reach > 1000I/U.",
      "start_char": 484,
      "end_char": 617,
      "entities_involved_ids": [
        "inst_26",
        "inst_27",
        "inst_28",
        "inst_29",
        "inst_30"
      ],
      "uncertainty_triggers": [
        {
          "trigger": "may be preceded",
          "category": "POSSIBLE_EXISTENCE"
        }
      ]
    },
    {
      "atom_type": "probabilistic_relation_hint",
      "id": "sent_10",
      "sentence_text": "An AST:ALT ratio of > 1.5 indicates intrahepatic (mechanical or medical) cholestasis is more likely.",
      "start_char": 902,
      "end_char": 1003,
      "entities_involved_ids": [
        "inst_45",
        "inst_46",
        "inst_47",
        "inst_48",
        "inst_49",
        "inst_50",
        "inst_51"
      ],
      "uncertainty_triggers": [
        {
          "trigger": "likely.\n",
          "category": "UNCERTAINTY"
        }
      ]
    },
    {
      "atom_type": "probabilistic_relation_hint",
      "id": "sent_11",
      "sentence_text": "Drug-induced cholestasis usually presents with a preferential rise in ALP, rather than GGT, or with an ALT:ALP ratio of<2.",
      "start_char": 1003,
      "end_char": 1126,
      "entities_involved_ids": [
        "inst_52",
        "inst_53",
        "inst_54",
        "inst_55",
        "inst_56",
        "inst_57",
        "inst_58",
        "inst_59"
      ],
      "uncertainty_triggers": [
        {
          "trigger": "rather than GGT",
          "category": "NEGATED_EXISTENCE"
        }
      ]
    },
    {
      "atom_type": "probabilistic_relation_hint",
      "id": "sent_15",
      "sentence_text": "If either of these two criteria is absent, imaging and liver biopsy become necessary.",
      "start_char": 1485,
      "end_char": 1571,
      "entities_involved_ids": [
        "inst_76",
        "inst_77",
        "inst_78",
        "inst_79"
      ],
      "uncertainty_triggers": [
        {
          "trigger": "If either",
          "category": "HYPOTHETICAL"
        }
      ]
    },
    {
      "atom_type": "probabilistic_relation_hint",
      "id": "sent_17",
      "sentence_text": "A recent study has shown that a raised AST:ALT ratio outperforms other non-histological indicators of cirrhosis in PBC, but still only achieves a low sensitivity and a specificity of 65-79%. As with PBC, liver enzymes play a key role in the diagnosis of Primary Sclerosing Cholangitis (PSC).",
      "start_char": 1694,
      "end_char": 1986,
      "entities_involved_ids": [
        "inst_87",
        "inst_88",
        "inst_89",
        "inst_90",
        "inst_91",
        "inst_92",
        "inst_93",
        "inst_94",
        "inst_95",
        "inst_96",
        "inst_97",
        "inst_98",
        "inst_99",
        "inst_100",
        "inst_101",
        "inst_102"
      ],
      "uncertainty_triggers": [
        {
          "trigger": "but still only",
          "category": "UNCERTAINTY"
        }
      ]
    },
    {
      "atom_type": "probabilistic_relation_hint",
      "id": "sent_18",
      "sentence_text": "Alcohol induces hepatic enzymes leading to a raised GGT with an ALP which may be normal, or disproportionately lower than the GGT.",
      "start_char": 1986,
      "end_char": 2117,
      "entities_involved_ids": [
        "inst_103",
        "inst_104",
        "inst_105",
        "inst_106",
        "inst_107",
        "inst_108",
        "inst_109",
        "inst_110",
        "inst_111"
      ],
      "uncertainty_triggers": [
        {
          "trigger": "may be normal",
          "category": "POSSIBLE_EXISTENCE"
        }
      ]
    },
    {
      "atom_type": "probabilistic_relation_hint",
      "id": "sent_21",
      "sentence_text": "A raised GGT is not diagnostic of alcohol abuse, with research showing it remains high in former drinkers as well as current drinkers.",
      "start_char": 2428,
      "end_char": 2567,
      "entities_involved_ids": [
        "inst_130",
        "inst_131",
        "inst_132",
        "inst_133",
        "inst_134",
        "inst_135",
        "inst_136"
      ],
      "uncertainty_triggers": [
        {
          "trigger": "is not diagnostic",
          "category": "NEGATED_EXISTENCE"
        }
      ]
    }
  ],
  "context_graph": {
    "targets": [
      {
        "id": "span_1587885b_1_31",
        "text": "Mechanical biliary obstruction",
        "category": "ENTITY",
        "start_char": 1,
        "end_char": 31
      },
      {
        "id": "span_1587885b_32_39",
        "text": "results",
        "category": "ENTITY",
        "start_char": 32,
        "end_char": 39
      },
      {
        "id": "span_1587885b_43_49",
        "text": "raised",
        "category": "ENTITY",
        "start_char": 43,
        "end_char": 49
      },
      {
        "id": "span_1587885b_50_56",
        "text": "levels",
        "category": "ENTITY",
        "start_char": 50,
        "end_char": 56
      },
      {
        "id": "span_1587885b_60_63",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 60,
        "end_char": 63
      },
      {
        "id": "span_1587885b_65_68",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 65,
        "end_char": 68
      },
      {
        "id": "span_1587885b_79_88",
        "text": "bilirubin",
        "category": "ENTITY",
        "start_char": 79,
        "end_char": 88
      },
      {
        "id": "span_1587885b_90_93",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 90,
        "end_char": 93
      },
      {
        "id": "span_1587885b_119_125",
        "text": "raised",
        "category": "ENTITY",
        "start_char": 119,
        "end_char": 125
      },
      {
        "id": "span_1587885b_129_139",
        "text": "comparison",
        "category": "ENTITY",
        "start_char": 129,
        "end_char": 139
      },
      {
        "id": "span_1587885b_145_157",
        "text": "ALT.s\nLevels",
        "category": "ENTITY",
        "start_char": 145,
        "end_char": 157
      },
      {
        "id": "span_1587885b_161_164",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 161,
        "end_char": 164
      },
      {
        "id": "span_1587885b_169_172",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 169,
        "end_char": 172
      },
      {
        "id": "span_1587885b_173_181",
        "text": "elevated",
        "category": "ENTITY",
        "start_char": 173,
        "end_char": 181
      },
      {
        "id": "span_1587885b_193_204",
        "text": "proportions",
        "category": "ENTITY",
        "start_char": 193,
        "end_char": 204
      },
      {
        "id": "span_1587885b_276_282",
        "text": "enzyme",
        "category": "ENTITY",
        "start_char": 276,
        "end_char": 282
      },
      {
        "id": "span_1587885b_327_346",
        "text": "choledocholithiasis",
        "category": "ENTITY",
        "start_char": 327,
        "end_char": 346
      },
      {
        "id": "span_1587885b_352_358",
        "text": "levels",
        "category": "ENTITY",
        "start_char": 352,
        "end_char": 358
      },
      {
        "id": "span_1587885b_362_365",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 362,
        "end_char": 365
      },
      {
        "id": "span_1587885b_370_373",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 370,
        "end_char": 373
      },
      {
        "id": "span_1587885b_382_391",
        "text": "fluctuate",
        "category": "ENTITY",
        "start_char": 382,
        "end_char": 391
      },
      {
        "id": "span_1587885b_396_406",
        "text": "comparison",
        "category": "ENTITY",
        "start_char": 396,
        "end_char": 406
      },
      {
        "id": "span_1587885b_410_435",
        "text": "stricture forming disease",
        "category": "ENTITY",
        "start_char": 410,
        "end_char": 435
      },
      {
        "id": "span_1587885b_448_463",
        "text": "associated with",
        "category": "ENTITY",
        "start_char": 448,
        "end_char": 463
      },
      {
        "id": "span_1587885b_466_472",
        "text": "normal",
        "category": "ENTITY",
        "start_char": 466,
        "end_char": 472
      },
      {
        "id": "span_1587885b_473_482",
        "text": "bilirubin",
        "category": "ENTITY",
        "start_char": 473,
        "end_char": 482
      },
      {
        "id": "span_1587885b_484_490",
        "text": "Enzyme",
        "category": "ENTITY",
        "start_char": 484,
        "end_char": 490
      },
      {
        "id": "span_1587885b_491_497",
        "text": "titres",
        "category": "ENTITY",
        "start_char": 491,
        "end_char": 497
      },
      {
        "id": "span_1587885b_515_519",
        "text": "fall",
        "category": "ENTITY",
        "start_char": 515,
        "end_char": 519
      },
      {
        "id": "span_1587885b_570_589",
        "text": "liver transaminases",
        "category": "ENTITY",
        "start_char": 570,
        "end_char": 589
      },
      {
        "id": "span_1587885b_614_617",
        "text": "U.\n",
        "category": "ENTITY",
        "start_char": 614,
        "end_char": 617
      },
      {
        "id": "span_1587885b_621_624",
        "text": "AST",
        "category": "ENTITY",
        "start_char": 621,
        "end_char": 624
      },
      {
        "id": "span_1587885b_625_634",
        "text": "ALT ratio",
        "category": "ENTITY",
        "start_char": 625,
        "end_char": 634
      },
      {
        "id": "span_1587885b_636_650",
        "text": "De Ritis ratio",
        "category": "ENTITY",
        "start_char": 636,
        "end_char": 650
      },
      {
        "id": "span_1587885b_686_690",
        "text": "site",
        "category": "ENTITY",
        "start_char": 686,
        "end_char": 690
      },
      {
        "id": "span_1587885b_694_713",
        "text": "biliary obstruction",
        "category": "ENTITY",
        "start_char": 694,
        "end_char": 713
      },
      {
        "id": "span_1587885b_720_735",
        "text": "associated with",
        "category": "ENTITY",
        "start_char": 720,
        "end_char": 735
      },
      {
        "id": "span_1587885b_738_757",
        "text": "cholestatic picture",
        "category": "ENTITY",
        "start_char": 738,
        "end_char": 757
      },
      {
        "id": "span_1587885b_762_765",
        "text": "AST",
        "category": "ENTITY",
        "start_char": 762,
        "end_char": 765
      },
      {
        "id": "span_1587885b_766_769",
        "text": "ALT",
        "category": "ENTITY",
        "start_char": 766,
        "end_char": 769
      },
      {
        "id": "span_1587885b_770_775",
        "text": "ratio",
        "category": "ENTITY",
        "start_char": 770,
        "end_char": 775
      },
      {
        "id": "span_1587885b_796_820",
        "text": "extrahepatic obstruction",
        "category": "ENTITY",
        "start_char": 796,
        "end_char": 820
      },
      {
        "id": "span_1587885b_848_857",
        "text": "ALT titre",
        "category": "ENTITY",
        "start_char": 848,
        "end_char": 857
      },
      {
        "id": "span_1587885b_885_891",
        "text": "higher",
        "category": "ENTITY",
        "start_char": 885,
        "end_char": 891
      },
      {
        "id": "span_1587885b_897_900",
        "text": "AST",
        "category": "ENTITY",
        "start_char": 897,
        "end_char": 900
      },
      {
        "id": "span_1587885b_905_908",
        "text": "AST",
        "category": "ENTITY",
        "start_char": 905,
        "end_char": 908
      },
      {
        "id": "span_1587885b_909_912",
        "text": "ALT",
        "category": "ENTITY",
        "start_char": 909,
        "end_char": 912
      },
      {
        "id": "span_1587885b_913_918",
        "text": "ratio",
        "category": "ENTITY",
        "start_char": 913,
        "end_char": 918
      },
      {
        "id": "span_1587885b_938_950",
        "text": "intrahepatic",
        "category": "ENTITY",
        "start_char": 938,
        "end_char": 950
      },
      {
        "id": "span_1587885b_952_962",
        "text": "mechanical",
        "category": "ENTITY",
        "start_char": 952,
        "end_char": 962
      },
      {
        "id": "span_1587885b_966_973",
        "text": "medical",
        "category": "ENTITY",
        "start_char": 966,
        "end_char": 973
      },
      {
        "id": "span_1587885b_975_986",
        "text": "cholestasis",
        "category": "ENTITY",
        "start_char": 975,
        "end_char": 986
      },
      {
        "id": "span_1587885b_1003_1007",
        "text": "Drug",
        "category": "ENTITY",
        "start_char": 1003,
        "end_char": 1007
      },
      {
        "id": "span_1587885b_1008_1015",
        "text": "induced",
        "category": "ENTITY",
        "start_char": 1008,
        "end_char": 1015
      },
      {
        "id": "span_1587885b_1016_1027",
        "text": "cholestasis",
        "category": "ENTITY",
        "start_char": 1016,
        "end_char": 1027
      },
      {
        "id": "span_1587885b_1073_1076",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 1073,
        "end_char": 1076
      },
      {
        "id": "span_1587885b_1090_1093",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 1090,
        "end_char": 1093
      },
      {
        "id": "span_1587885b_1106_1109",
        "text": "ALT",
        "category": "ENTITY",
        "start_char": 1106,
        "end_char": 1109
      },
      {
        "id": "span_1587885b_1110_1113",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 1110,
        "end_char": 1113
      },
      {
        "id": "span_1587885b_1114_1119",
        "text": "ratio",
        "category": "ENTITY",
        "start_char": 1114,
        "end_char": 1119
      },
      {
        "id": "span_1587885b_1126_1141",
        "text": "Causative drugs",
        "category": "ENTITY",
        "start_char": 1126,
        "end_char": 1141
      },
      {
        "id": "span_1587885b_1157_1168",
        "text": "antibiotics",
        "category": "ENTITY",
        "start_char": 1157,
        "end_char": 1168
      },
      {
        "id": "span_1587885b_1170_1188",
        "text": "immunosuppressants",
        "category": "ENTITY",
        "start_char": 1170,
        "end_char": 1188
      },
      {
        "id": "span_1587885b_1190_1199",
        "text": "tricyclic",
        "category": "ENTITY",
        "start_char": 1190,
        "end_char": 1199
      },
      {
        "id": "span_1587885b_1200_1215",
        "text": "antidepressants",
        "category": "ENTITY",
        "start_char": 1200,
        "end_char": 1215
      },
      {
        "id": "span_1587885b_1220_1260",
        "text": "angiotensin converting enzyme inhibitors",
        "category": "ENTITY",
        "start_char": 1220,
        "end_char": 1260
      },
      {
        "id": "span_1587885b_1265_1290",
        "text": "Primary Biliary Cirrhosis",
        "category": "ENTITY",
        "start_char": 1265,
        "end_char": 1290
      },
      {
        "id": "span_1587885b_1295_1315",
        "text": "autoimmune condition",
        "category": "ENTITY",
        "start_char": 1295,
        "end_char": 1315
      },
      {
        "id": "span_1587885b_1323_1335",
        "text": "intrahepatic",
        "category": "ENTITY",
        "start_char": 1323,
        "end_char": 1335
      },
      {
        "id": "span_1587885b_1336_1349",
        "text": "biliary ducts",
        "category": "ENTITY",
        "start_char": 1336,
        "end_char": 1349
      },
      {
        "id": "span_1587885b_1355_1360",
        "text": "level",
        "category": "ENTITY",
        "start_char": 1355,
        "end_char": 1360
      },
      {
        "id": "span_1587885b_1364_1367",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 1364,
        "end_char": 1367
      },
      {
        "id": "span_1587885b_1402_1405",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 1402,
        "end_char": 1405
      },
      {
        "id": "span_1587885b_1421_1434",
        "text": "transaminases",
        "category": "ENTITY",
        "start_char": 1421,
        "end_char": 1434
      },
      {
        "id": "span_1587885b_1450_1456",
        "text": "normal",
        "category": "ENTITY",
        "start_char": 1450,
        "end_char": 1456
      },
      {
        "id": "span_1587885b_1475_1483",
        "text": "elevated",
        "category": "ENTITY",
        "start_char": 1475,
        "end_char": 1483
      },
      {
        "id": "span_1587885b_1508_1516",
        "text": "criteria",
        "category": "ENTITY",
        "start_char": 1508,
        "end_char": 1516
      },
      {
        "id": "span_1587885b_1520_1526",
        "text": "absent",
        "category": "ENTITY",
        "start_char": 1520,
        "end_char": 1526
      },
      {
        "id": "span_1587885b_1528_1535",
        "text": "imaging",
        "category": "ENTITY",
        "start_char": 1528,
        "end_char": 1535
      },
      {
        "id": "span_1587885b_1540_1552",
        "text": "liver biopsy",
        "category": "ENTITY",
        "start_char": 1540,
        "end_char": 1552
      },
      {
        "id": "span_1587885b_1571_1574",
        "text": "AST",
        "category": "ENTITY",
        "start_char": 1571,
        "end_char": 1574
      },
      {
        "id": "span_1587885b_1579_1582",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 1579,
        "end_char": 1582
      },
      {
        "id": "span_1587885b_1604_1620",
        "text": "scoring criteria",
        "category": "ENTITY",
        "start_char": 1604,
        "end_char": 1620
      },
      {
        "id": "span_1587885b_1636_1646",
        "text": "effects of",
        "category": "ENTITY",
        "start_char": 1636,
        "end_char": 1646
      },
      {
        "id": "span_1587885b_1647_1667",
        "text": "ursodeoxycholic acid",
        "category": "ENTITY",
        "start_char": 1647,
        "end_char": 1667
      },
      {
        "id": "span_1587885b_1675_1685",
        "text": "management",
        "category": "ENTITY",
        "start_char": 1675,
        "end_char": 1685
      },
      {
        "id": "span_1587885b_1689_1692",
        "text": "PBC",
        "category": "ENTITY",
        "start_char": 1689,
        "end_char": 1692
      },
      {
        "id": "span_1587885b_1726_1732",
        "text": "raised",
        "category": "ENTITY",
        "start_char": 1726,
        "end_char": 1732
      },
      {
        "id": "span_1587885b_1733_1736",
        "text": "AST",
        "category": "ENTITY",
        "start_char": 1733,
        "end_char": 1736
      },
      {
        "id": "span_1587885b_1737_1740",
        "text": "ALT",
        "category": "ENTITY",
        "start_char": 1737,
        "end_char": 1740
      },
      {
        "id": "span_1587885b_1741_1746",
        "text": "ratio",
        "category": "ENTITY",
        "start_char": 1741,
        "end_char": 1746
      },
      {
        "id": "span_1587885b_1765_1768",
        "text": "non",
        "category": "ENTITY",
        "start_char": 1765,
        "end_char": 1768
      },
      {
        "id": "span_1587885b_1769_1792",
        "text": "histological indicators",
        "category": "ENTITY",
        "start_char": 1769,
        "end_char": 1792
      },
      {
        "id": "span_1587885b_1796_1805",
        "text": "cirrhosis",
        "category": "ENTITY",
        "start_char": 1796,
        "end_char": 1805
      },
      {
        "id": "span_1587885b_1809_1812",
        "text": "PBC",
        "category": "ENTITY",
        "start_char": 1809,
        "end_char": 1812
      },
      {
        "id": "span_1587885b_1840_1843",
        "text": "low",
        "category": "ENTITY",
        "start_char": 1840,
        "end_char": 1843
      },
      {
        "id": "span_1587885b_1844_1855",
        "text": "sensitivity",
        "category": "ENTITY",
        "start_char": 1844,
        "end_char": 1855
      },
      {
        "id": "span_1587885b_1862_1873",
        "text": "specificity",
        "category": "ENTITY",
        "start_char": 1862,
        "end_char": 1873
      },
      {
        "id": "span_1587885b_1893_1896",
        "text": "PBC",
        "category": "ENTITY",
        "start_char": 1893,
        "end_char": 1896
      },
      {
        "id": "span_1587885b_1898_1911",
        "text": "liver enzymes",
        "category": "ENTITY",
        "start_char": 1898,
        "end_char": 1911
      },
      {
        "id": "span_1587885b_1935_1944",
        "text": "diagnosis",
        "category": "ENTITY",
        "start_char": 1935,
        "end_char": 1944
      },
      {
        "id": "span_1587885b_1948_1978",
        "text": "Primary Sclerosing Cholangitis",
        "category": "ENTITY",
        "start_char": 1948,
        "end_char": 1978
      },
      {
        "id": "span_1587885b_1980_1983",
        "text": "PSC",
        "category": "ENTITY",
        "start_char": 1980,
        "end_char": 1983
      },
      {
        "id": "span_1587885b_1986_1993",
        "text": "Alcohol",
        "category": "ENTITY",
        "start_char": 1986,
        "end_char": 1993
      },
      {
        "id": "span_1587885b_1994_2001",
        "text": "induces",
        "category": "ENTITY",
        "start_char": 1994,
        "end_char": 2001
      },
      {
        "id": "span_1587885b_2002_2017",
        "text": "hepatic enzymes",
        "category": "ENTITY",
        "start_char": 2002,
        "end_char": 2017
      },
      {
        "id": "span_1587885b_2031_2037",
        "text": "raised",
        "category": "ENTITY",
        "start_char": 2031,
        "end_char": 2037
      },
      {
        "id": "span_1587885b_2038_2041",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 2038,
        "end_char": 2041
      },
      {
        "id": "span_1587885b_2050_2053",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 2050,
        "end_char": 2053
      },
      {
        "id": "span_1587885b_2067_2073",
        "text": "normal",
        "category": "ENTITY",
        "start_char": 2067,
        "end_char": 2073
      },
      {
        "id": "span_1587885b_2078_2096",
        "text": "disproportionately",
        "category": "ENTITY",
        "start_char": 2078,
        "end_char": 2096
      },
      {
        "id": "span_1587885b_2112_2115",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 2112,
        "end_char": 2115
      },
      {
        "id": "span_1587885b_2119_2122",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 2119,
        "end_char": 2122
      },
      {
        "id": "span_1587885b_2124_2127",
        "text": "ALP",
        "category": "ENTITY",
        "start_char": 2124,
        "end_char": 2127
      },
      {
        "id": "span_1587885b_2128_2133",
        "text": "ratio",
        "category": "ENTITY",
        "start_char": 2128,
        "end_char": 2133
      },
      {
        "id": "span_1587885b_2143_2154",
        "text": "association",
        "category": "ENTITY",
        "start_char": 2143,
        "end_char": 2154
      },
      {
        "id": "span_1587885b_2160_2168",
        "text": "jaundice",
        "category": "ENTITY",
        "start_char": 2160,
        "end_char": 2168
      },
      {
        "id": "span_1587885b_2178_2185",
        "text": "alcohol",
        "category": "ENTITY",
        "start_char": 2178,
        "end_char": 2185
      },
      {
        "id": "span_1587885b_2200_2213",
        "text": "liver disease",
        "category": "ENTITY",
        "start_char": 2200,
        "end_char": 2213
      },
      {
        "id": "span_1587885b_2219_2227",
        "text": "presence",
        "category": "ENTITY",
        "start_char": 2219,
        "end_char": 2227
      },
      {
        "id": "span_1587885b_2233_2245",
        "text": "macrocytosis",
        "category": "ENTITY",
        "start_char": 2233,
        "end_char": 2245
      },
      {
        "id": "span_1587885b_2264_2274",
        "text": "associated",
        "category": "ENTITY",
        "start_char": 2264,
        "end_char": 2274
      },
      {
        "id": "span_1587885b_2275_2293",
        "text": "dietary deficiency",
        "category": "ENTITY",
        "start_char": 2275,
        "end_char": 2293
      },
      {
        "id": "span_1587885b_2297_2303",
        "text": "folate",
        "category": "ENTITY",
        "start_char": 2297,
        "end_char": 2303
      },
      {
        "id": "span_1587885b_2307_2310",
        "text": "B12",
        "category": "ENTITY",
        "start_char": 2307,
        "end_char": 2310
      },
      {
        "id": "span_1587885b_2331_2342",
        "text": "suppression",
        "category": "ENTITY",
        "start_char": 2331,
        "end_char": 2342
      },
      {
        "id": "span_1587885b_2346_2357",
        "text": "bone marrow",
        "category": "ENTITY",
        "start_char": 2346,
        "end_char": 2357
      },
      {
        "id": "span_1587885b_2361_2368",
        "text": "alcohol",
        "category": "ENTITY",
        "start_char": 2361,
        "end_char": 2368
      },
      {
        "id": "span_1587885b_2390_2399",
        "text": "diagnosis",
        "category": "ENTITY",
        "start_char": 2390,
        "end_char": 2399
      },
      {
        "id": "span_1587885b_2403_2426",
        "text": "alcoholic liver disease",
        "category": "ENTITY",
        "start_char": 2403,
        "end_char": 2426
      },
      {
        "id": "span_1587885b_2430_2436",
        "text": "raised",
        "category": "ENTITY",
        "start_char": 2430,
        "end_char": 2436
      },
      {
        "id": "span_1587885b_2437_2440",
        "text": "GGT",
        "category": "ENTITY",
        "start_char": 2437,
        "end_char": 2440
      },
      {
        "id": "span_1587885b_2448_2458",
        "text": "diagnostic",
        "category": "ENTITY",
        "start_char": 2448,
        "end_char": 2458
      },
      {
        "id": "span_1587885b_2462_2475",
        "text": "alcohol abuse",
        "category": "ENTITY",
        "start_char": 2462,
        "end_char": 2475
      },
      {
        "id": "span_1587885b_2482_2490",
        "text": "research",
        "category": "ENTITY",
        "start_char": 2482,
        "end_char": 2490
      },
      {
        "id": "span_1587885b_2518_2533",
        "text": "former drinkers",
        "category": "ENTITY",
        "start_char": 2518,
        "end_char": 2533
      },
      {
        "id": "span_1587885b_2553_2561",
        "text": "drinkers",
        "category": "ENTITY",
        "start_char": 2553,
        "end_char": 2561
      }
    ],
    "modifiers": [
      {
        "id": "span_1587885b_259_275",
        "text": "causes of single",
        "category": "NEGATED_EXISTENCE",
        "start_char": 259,
        "end_char": 275
      },
      {
        "id": "span_1587885b_441_458",
        "text": "may be associated",
        "category": "POSSIBLE_EXISTENCE",
        "start_char": 441,
        "end_char": 458
      },
      {
        "id": "span_1587885b_534_549",
        "text": "may be preceded",
        "category": "POSSIBLE_EXISTENCE",
        "start_char": 534,
        "end_char": 549
      },
      {
        "id": "span_1587885b_995_1003",
        "text": "likely.\n",
        "category": "UNCERTAINTY",
        "start_char": 995,
        "end_char": 1003
      },
      {
        "id": "span_1587885b_1036_1051",
        "text": "presents with a",
        "category": "CO-OCCURRENCE",
        "start_char": 1036,
        "end_char": 1051
      },
      {
        "id": "span_1587885b_1078_1093",
        "text": "rather than GGT",
        "category": "NEGATED_EXISTENCE",
        "start_char": 1078,
        "end_char": 1093
      },
      {
        "id": "span_1587885b_1485_1494",
        "text": "If either",
        "category": "HYPOTHETICAL",
        "start_char": 1485,
        "end_char": 1494
      },
      {
        "id": "span_1587885b_1814_1828",
        "text": "but still only",
        "category": "UNCERTAINTY",
        "start_char": 1814,
        "end_char": 1828
      },
      {
        "id": "span_1587885b_2060_2073",
        "text": "may be normal",
        "category": "POSSIBLE_EXISTENCE",
        "start_char": 2060,
        "end_char": 2073
      },
      {
        "id": "span_1587885b_2186_2205",
        "text": "as a cause of liver",
        "category": "NEGATED_EXISTENCE",
        "start_char": 2186,
        "end_char": 2205
      },
      {
        "id": "span_1587885b_2441_2458",
        "text": "is not diagnostic",
        "category": "NEGATED_EXISTENCE",
        "start_char": 2441,
        "end_char": 2458
      }
    ],
    "edges": [
      {
        "target_id": "span_1587885b_448_463",
        "modifier_id": "span_1587885b_441_458"
      },
      {
        "target_id": "span_1587885b_466_472",
        "modifier_id": "span_1587885b_441_458"
      },
      {
        "target_id": "span_1587885b_473_482",
        "modifier_id": "span_1587885b_441_458"
      },
      {
        "target_id": "span_1587885b_570_589",
        "modifier_id": "span_1587885b_534_549"
      },
      {
        "target_id": "span_1587885b_614_617",
        "modifier_id": "span_1587885b_534_549"
      },
      {
        "target_id": "span_1587885b_905_908",
        "modifier_id": "span_1587885b_995_1003"
      },
      {
        "target_id": "span_1587885b_909_912",
        "modifier_id": "span_1587885b_995_1003"
      },
      {
        "target_id": "span_1587885b_913_918",
        "modifier_id": "span_1587885b_995_1003"
      },
      {
        "target_id": "span_1587885b_938_950",
        "modifier_id": "span_1587885b_995_1003"
      },
      {
        "target_id": "span_1587885b_952_962",
        "modifier_id": "span_1587885b_995_1003"
      },
      {
        "target_id": "span_1587885b_966_973",
        "modifier_id": "span_1587885b_995_1003"
      },
      {
        "target_id": "span_1587885b_975_986",
        "modifier_id": "span_1587885b_995_1003"
      },
      {
        "target_id": "span_1587885b_1073_1076",
        "modifier_id": "span_1587885b_1036_1051"
      },
      {
        "target_id": "span_1587885b_1090_1093",
        "modifier_id": "span_1587885b_1036_1051"
      },
      {
        "target_id": "span_1587885b_1106_1109",
        "modifier_id": "span_1587885b_1036_1051"
      },
      {
        "target_id": "span_1587885b_1110_1113",
        "modifier_id": "span_1587885b_1036_1051"
      },
      {
        "target_id": "span_1587885b_1114_1119",
        "modifier_id": "span_1587885b_1036_1051"
      },
      {
        "target_id": "span_1587885b_1090_1093",
        "modifier_id": "span_1587885b_1078_1093"
      },
      {
        "target_id": "span_1587885b_1106_1109",
        "modifier_id": "span_1587885b_1078_1093"
      },
      {
        "target_id": "span_1587885b_1110_1113",
        "modifier_id": "span_1587885b_1078_1093"
      },
      {
        "target_id": "span_1587885b_1114_1119",
        "modifier_id": "span_1587885b_1078_1093"
      },
      {
        "target_id": "span_1587885b_1508_1516",
        "modifier_id": "span_1587885b_1485_1494"
      },
      {
        "target_id": "span_1587885b_1520_1526",
        "modifier_id": "span_1587885b_1485_1494"
      },
      {
        "target_id": "span_1587885b_1528_1535",
        "modifier_id": "span_1587885b_1485_1494"
      },
      {
        "target_id": "span_1587885b_1540_1552",
        "modifier_id": "span_1587885b_1485_1494"
      },
      {
        "target_id": "span_1587885b_1840_1843",
        "modifier_id": "span_1587885b_1814_1828"
      },
      {
        "target_id": "span_1587885b_1844_1855",
        "modifier_id": "span_1587885b_1814_1828"
      },
      {
        "target_id": "span_1587885b_1862_1873",
        "modifier_id": "span_1587885b_1814_1828"
      },
      {
        "target_id": "span_1587885b_1893_1896",
        "modifier_id": "span_1587885b_1814_1828"
      },
      {
        "target_id": "span_1587885b_1898_1911",
        "modifier_id": "span_1587885b_1814_1828"
      },
      {
        "target_id": "span_1587885b_1935_1944",
        "modifier_id": "span_1587885b_1814_1828"
      },
      {
        "target_id": "span_1587885b_1948_1978",
        "modifier_id": "span_1587885b_1814_1828"
      },
      {
        "target_id": "span_1587885b_1980_1983",
        "modifier_id": "span_1587885b_1814_1828"
      },
      {
        "target_id": "span_1587885b_2067_2073",
        "modifier_id": "span_1587885b_2060_2073"
      },
      {
        "target_id": "span_1587885b_2078_2096",
        "modifier_id": "span_1587885b_2060_2073"
      },
      {
        "target_id": "span_1587885b_2112_2115",
        "modifier_id": "span_1587885b_2060_2073"
      },
      {
        "target_id": "span_1587885b_2448_2458",
        "modifier_id": "span_1587885b_2441_2458"
      },
      {
        "target_id": "span_1587885b_2462_2475",
        "modifier_id": "span_1587885b_2441_2458"
      },
      {
        "target_id": "span_1587885b_2482_2490",
        "modifier_id": "span_1587885b_2441_2458"
      },
      {
        "target_id": "span_1587885b_2518_2533",
        "modifier_id": "span_1587885b_2441_2458"
      },
      {
        "target_id": "span_1587885b_2553_2561",
        "modifier_id": "span_1587885b_2441_2458"
      }
    ]
  }
}